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 miRNAs are important regulators of gene expression. These small RNAs 
function throughout development and regulate translation of a number mRNAs. 
miRNAs exert their affect on translation as part of the RNP complex RISC. RISC 
can affect translation of transcripts at both the level of translation initiation, and 
post-initiation. Although mechanisms of repression mediated by miRNAs have 
been intensively studied, repression is not well characterized. In order to 
understand how miRNAs regulate translation in Drosophila, we first characterized 
miRNA-mediated repression in the ovary.  We developed an ovarian assay 
sensitive to regulation by miRNAs and found that regulated transcripts localize to 
cytoplasmic puncta distinct from sponge bodies, cytoplasmic RNP structures 
consisting of proteins implicated in miRNA-mediated regulation. In addition, we 
 vii 
devised a genetic screen to identify genes involved in miRNA-mediated 
regulation.  Seven mutants were isolated from the screen, and two mutants were 
subsequently mapped to separate 1Mb genomic regions.  Both these regions are 
devoid of genes implicated in miRNA-mediated regulation, suggesting our 
mutants identify novel components involved in repression. 
The oskar mRNA encodes the Oskar protein, which is vital in establishing 
the posterior axis of the Drosophila embryo.  In addition to its protein coding 
function, the osk mRNA has another essential role: it is required for egg chamber 
progression through oogenesis. This role of oskar is mediated by its 3ʼ UTR, but 
how it functions in this role is unknown.  Here, we investigate the function of the 
3ʼ UTR and discover that the well-defined BRE sequences are required for egg 
chamber progression through oogenesis. The BREs mediate translational 
repression of the highly regulated oskar mRNA and were previously defined by 
their ability to bind Bruno, which represses translation of the oskar mRNA. We 
also provide evidence that the osk BREs sequester Bruno, potentially inhibiting 
Bruno from binding and misregulating other mRNAs.  Our results suggest a novel 
regulatory loop, where oskar sequesters and inhibits Bruno from misregulating 
mRNAs, and Bruno, in turn, regulates translation of the oskar mRNA. 
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Chapter 1: General Introduction 
 
The focus of this thesis is post-transcriptional regulation in Drosophila 
melanogaster.  Post-transcriptional control of gene regulation is an important 
aspect in the development of a number of organisms (reviewed in (Besse and 
Ephrussi, 2008; Richter and Sonenberg, 2005). One form of post-transcriptional 
control is miRNA-mediated regulation. miRNA-mediated regulation can occur 
through various, distinct mechanisms. The mechanism employed depends on the 
regulated transcript, and the proteins involved in its regulation (reviewed in 
Carthew and Sontheimer, 2009).  In order to understand the different 
mechanisms involved in miRNA-mediated regulation, a number of genes have 
been identified that function during regulation, but others remain to be identified 
(Bhattacharyya et al., 2006; Chendrimada et al., 2007; Eulalio et al., 2007; 
Hammell et al., 2009; Schwamborn et al., 2009; Weinmann et al., 2009; Lee et 
al., 2009). A major aim of this thesis is to understand the mechanisms of miRNA-
mediated gene regulation.  
The Drosophila ovary is a tissue rich in post-transcriptional control. A 
number of ovarian mRNAs are regulated to ensure protein translation occurs at 
the correct place and time during development. One highly regulated mRNA, the 
oskar (osk) mRNA (Kim-Ha et al., 1991; Ephrussi et al., 1991; Kim-Ha et al., 
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1995), has an important function during oogenesis in addition to its protein coding 
function; flies that lack the oskar mRNA arrest in oogenesis (Jenny et al., 2006). 
Another major aim of this thesis is to elucidate the function of the osk mRNA 
during oogenesis.  
POST-TRANSCRIPTIONAL CONTROL 
Some mechanisms of post-transcriptional regulation directly affect the 
process of protein translation, either during translational initiation or post-initiation 
(reviewed in (Mendez and Richter, 2001; Richter and Sonenberg, 2005; Besse 
and Ephrussi, 2008). Many different mechanisms affect translation initiation. One 
mechanism acts through sequences in the 5ʼ UTR, causing translational 
repression of the mRNA, possibly by impeding ribosome entry (Kozak, 2005). 
Regulation of initiation also occurs through inhibition of the 43S ribosomal 
initiation complex binding to an mRNAs 5ʼ cap (Richter and Sonenberg, 2005). In 
addition, poly(A) tail length can affect translation initiation. During development, 
repressed transcripts often contain a short poly(A) tail. Once translationally 
activated, the poly(A) tail length increases. Poly(A)-binding protein (PABP) is a 
positive regulator of translation that can bind transcripts with long poly (A) tails, 
promoting assembly of the 43S initiation complex on the transcript (Mendez and 
Richter, 2001).  
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Regulation of translation also occurs after translation initiation. Some 
translationally repressed mRNAs associate with actively translating ribosomes in 
the absence of protein accumulation. The mechanism behind this type of 
regulation is not well understood (Olsen and Ambros, 1999;  Braat et al., 2004; 
Clark et al., 2000; Petersen et al., 2006; Nottrott et al, 2006).   
A number of translationally quiescent mRNAs are found in RNP particles, 
complexes consisting of RNA and proteins (reviewed in Keene, 2001). 
Conglomerates of RNP complexes form cytoplasmic structures that are found 
throughout development (reviewed in (Anderson and Kedersha, 2009; Eulalio et 
al., 2007) . These structures can aid in localizing mRNAs to specific cellular 
locations where the mRNAs are then translated. In Drosophila egg chambers, 
RNP structures that facilitate the transport of maternal mRNAs to their correct 
destination are called sponge bodies (Wilsch-Brauninger et al., 1997). Neuronal 
cells contain RNP complexes (RNA granules) involved in localizing mRNAs to 
specific sites in the cell, where they can be translated in response to an external 
signal (Krichevsky and Kosik, 2001). Cytoplasmic RNP structures are also 
involved in mRNA storage and metabolism. P-bodies are cytoplasmic RNP 
structures found in somatic cells, involved in processes as diverse as mRNA 
degradation to storage of mRNAs for future use (Sheth and Parker, 2003; 
Brengues et al., 2005). 
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POST-TRANSCRIPTIONAL CONTROL IN THE OVARY 
Drosophila ovaries are comprised of about 16 ovarioles. Each ovariole 
contains a number of egg chambers in different stages of oogenesis, the 
developmental process of egg production. The egg chambers are made up of 
three cell types: the oocyte, the nurse cells, and the follicle cells. The nurse cells 
and oocyte are derived from the germline, while the follicle cells are somatic 
epithelial cells that surround the egg chamber. Nurse cells supply essential 
cytoplasmic components and mRNAs to the oocyte. At the end of oogenesis, the 
oocyte gives rise to the mature egg (Spradling, 1993; Bastock and St Johnston, 
2008). 
The Drosophila ovary is a tissue rich in post-transcriptional control.  
Embryonic body patterning relies on events that occur in the ovary, and is 
dependent on the proper localization and translation of a number of mRNAs.  
These mRNAs are transcribed in the nurse cells, where they are translationally 
quiescent. Following transcription, they are deposited in, and localized to specific 
regions of the oocyte (reviewed in (Lipshitz and Smibert, 2000; Palacios and St 
Johnston, 2001; Huynh and St Johnston, 2004). Localization and translation of 
the gurken (grk) mRNA at the anterior of the oocyte is responsible for the 
establishment of the dorso-ventral axis (Neuman-Silberberg and Schupbach, 
1993; Neuman-Silberberg and Schupbach, 1994). The translationally repressed 
bicoid (bcd) mRNA is also localized to the anterior of the oocyte.  Translation of 
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Bicoid in the embryo is required to form the embryonic head and other anterior 
elements (Frohnhofer and Nusslein-Volhard, 1987, Salles et al., 1994). 
Patterning of the posterior of the embryo requires the osk gene. Similar to the bcd 
and grk mRNAs, proper localization and expression of osk is essential for its 
function (Kim-Ha et al., 1991; Ephrussi et al., 1991; Ephrussi and Lehmann, 
1992; Smith et al., 1992; Kim-Ha et al., 1995.)  
Oskar 
The osk gene is essential for embryonic development. Females with 
protein null mutations in the osk gene give rise to embryos that lack both an 
abdomen and pole cells (Lehmann and Nusslein-Volhard, 1986). Proper 
formation of the embryo is also dependent on how much osk is present; too many 
copies of osk cause defects in head formation (Smith et al., 1992; Ephrussi and 
Lehmann, 1992). In addition to its protein coding function, the osk mRNA has an 
important role in oogenesis. Egg chambers that lack osk mRNA fail to progress 
through oogenesis (Jenny et al., 2006). How the osk mRNA performs this 
function is not known. 
The osk mRNA is provided to the oocyte by the nurse cells. osk mRNA is 
translationally repressed until it is localized to the posterior of the oocyte at stage 
9 of oogenesis. After the mRNA is localized and translated, Osk protein initiates 
formation of the pole plasm, which is required for posterior patterning and germ 
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cell formation (Kim-Ha et al., 1991; Ephrussi and Lehmann, 1992; Kim-Ha et al., 
1995; Rongo et al., 1995; Markussen et al., 1995). 
The osk 3ʼ UTR is necessary for translational repression of the osk mRNA 
(Kim-Ha et al., 1995). Two regions of the 3ʼ UTR have well defined sequences 
that mediate repression: the AB and the C region. These regions contain the 
sequence U(G/A)U(A/G)U(G/A)U, known as the Bruno Response Element 
(BRE), which bind to the translational repressor Bruno (Bru). Bru binding to the 
osk mRNA confers translational repression until the mRNA is localized to the 
posterior of the oocyte (Kim-Ha et al., 1995; Lie and Macdonald, 1999). 
Bruno 
The arrest (aret) gene is essential during ovary and sperm development 
and encodes the RNA binding protein Bru  (Schupbach and Wieschaus, 1991; 
Castrillon et al., 1993; Webster et al., 1997). Females that are mutant for a strong 
loss of function aret allele produce egg chambers that arrest in oogenesis, while 
aret mutant males are sterile (Schupbach and Wieschaus, 1991; Castrillon et al., 
1993; Webster et al., 1997). The presence of too much Bru also causes 
deleterious effects; ovaries that over-express Bru arrest in oogenesis (Filardo 
and Ephrussi, 2003). In addition to the osk mRNA, Bru regulates other transcripts 
important for proper development, such as gurken (grk), Cyclin A (CycA), germ 
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cell-less (gcl), and Sex-lethal (Sxl) (Filardo and Ephrussi, 2003; Webster et al., 
1997; Sugimura and Lilly, 2006; Moore et al., 2009; Wang and Lin, 2007). 
The Bru protein contains three copies of the RNA Recognition Motif 
(RRM). The RRMs in Bru bind RNA and are essential for Bru function (Snee et 
al., 2008; Webster et al., 1997). Egg chambers with a mutation in the first RRM of 
Bru progress to stage 9 of oogenesis, after which they degenerate (Webster et 
al., 1997). Once bound to an mRNA, Bru can translationally repress it. Different 
mechanisms for how Bru represses translation have been proposed, all of which 
are modeled after its regulation of the osk mRNA. One proposed mechanism of 
Bru-mediated repression relies on the interaction of Bru with the eIF4E binding 
protein, Cup.  Cup protein is recruited to the osk mRNA through its interaction 
with Bru. Cup can then interact with eIF4E, possibly inhibiting eIF4E binding to 
the osk 5ʼ cap and consequently, translation initiation (Nakamura et al., 2004). 
Another proposed mechanism of Bru-mediated repression is Cup independent. 
Reporter mRNAs containing osk AB region BREs are repressed in a cup mutant 
background. These translationally repressed reporter mRNAs oligomerize, and 
are found in large RNP complexes called silencing particles. Reporter mRNA 
association in silencing particles is dependent on the AB region BREs and Bruno 
(Chekulaeva et al., 2006) 
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MIRNAS 
miRNAs are small RNAs that are involved in multiple aspects of 
development. miRNAs were first identified in C. elegans where the lin-4 miRNA 
regulates the lin-14 and lin-28 transcripts (Olsen and Ambros, 1999; Moss et al., 
1997; Lee et al., 1993). Since then, miRNAs have been identified in a variety of 
organisms [Pfeffer et al., 2004; reviewed in (Bartel, 2004; Murchison and 
Hannon, 2004)]. miRNA-mediated regulation occurs post-transcriptionally, and 
generally provides a modest degree of translational repression (Baek et al., 
2008). The majority of miRNAs are thought to fine-tune the amounts of specific 
proteins in a cell. In support of this, miR-7 was recently shown to help buffer a 
number of signaling pathways against temperature fluctuations in Drosophila (Li 
et al., 2009).  
miRNAs are on average 22 nucleotides in length. Encoded within the 
genome, miRNAs are synthesized as long precursor transcripts, called pri-
miRNAs (Lee et al., 2002). Drosha and Pasha process pri-miRNAs in the nucleus 
into a 60 nt pre-miRNA (Denli et al., 2004; Gregory et al., 2004). The pre-miRNA 
is then exported out of the nucleus and processed further by the RNase III 
enzyme Dicer, and the dsRNA binding protein Loquacious (Loqs), giving rise to 
the mature miRNA (Jiang et al., 2005; Forstemann et al., 2005). After processing, 
the mature miRNA is loaded into the RNA Induced Silencing Complex (RISC), the 
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RNP complex that mediates repression (Okamura et al., 2004; Forstemann et al., 
2007).  
RISC 
miRNA-mediated regulation is dependent on RISC function. RISC consists 
of three core components: the targeting miRNA, an Argonaute protein, and 
GW182 (Eulalio et al., 2008; Eulalio et al., 2009). The specificity of RISC is 
provided by the sequence of the miRNA, with the first 2-8 nucleotides being the 
most important in recognizing and hybridizing to a target mRNA (Baek et al., 
2008; Brennecke et al., 2005). miRNA-mediated translational repression involves 
different effector proteins depending on the transcript that is regulated. The use 
of different effector proteins may help decide the regulated transcripts fate: 
degradation, translational repression, or activation (Weimann et al., 2009; Eulalio 
et al., 2007; Chendrimada et al., 2007; Bhattacharyya et al., 2006; Chu and 
Rana, 2006; Vasudevan et al., 2007; Neumuller et al., 2008; Schwamborn et al., 
2009; Ashraf et al., 2006).  
Argonaute  
Argonaute proteins are a core component of RISC. They are highly 
conserved, basic proteins found in organisms ranging from bacteria to mammals.  
There are two different types of Argonaute proteins based on sequence 
similarity—those similar to Drosophila Piwi, and those similar to Arabidopsis 
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Ago1. Argonaute proteins in various organisms have roles throughout 
development ranging from stem cell renewal to tissue morphogenesis (Carmell et 
al., 2002). 
There are 5 different Argonaute paralogs in Drosophila: AGO1, AGO2, 
AGO3, aubergine (aub), and piwi. The different Drosophila Argonautes have 
different functions. Both piwi and aub are involved in stem cell maintenance and 
heterochromatin formation (Carmell et al., 2002; Pal-Bhadra et al., 2004). In 
addition, aub is involved with RNAi in activated eggs, eggs mutant for aub lack 
RNAi activity (Kennerdell et al, 2002). These functions may be attributed to the 
involvement of piwi and aub with the piRNA pathway, in which AGO3 also 
functions (Brennecke et al., 2007). Drosophila AGO1 and AGO2 both form 
cleavage competent RISC complexes necessary for RNAi. In embryo lysates, 
AGO2 is required for siRNA directed cleavage of transcripts; AGO1 is required 
for miRNA directed cleavage of transcripts. In addition, AGO1 is associated with 
Dicer-1, which is responsible for processing miRNAs in Drosophila (Okamura et 
al., 2004). RNAi knockdowns of either AGO1 or AGO2 in S2 cells cause an up 
regulation of mRNAs, knockdowns of aub or piwi do not. Although there is some 
overlap in transcripts that are up regulated by knockdowns in AGO1 or AGO2, 
there is a huge amount of overlap between knockdowns of AGO1 and other 
miRNA pathway components such as drosha and GW182  (Rehwinkel et al, 
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2006). This highly suggests AGO1 is the Drosophila Argonaute protein involved 
in miRNA-mediated repression. 
All Argonaute proteins contain two conserved domains: a PAZ domain and 
a Piwi domain. Both domains are required for complete Argonaute function.  The 
function of each domain has been determined through crystal structure and 
mutagenesis combined with biochemical assays. The PAZ domain binds to small 
RNAs that have been processed by Dicer (Ma et al., 2004). The Piwi domain is 
similar to RNase H and, in some Argonaute proteins, is able to cleave the small 
RNA-mRNA hybrid, the mechanism of regulation used in RNAi (Song et al., 
2004). Cleavage capability requires a DDE motif, as mutations in this motif 
abolish Argonaute cleavage ability. Not all Argonaute proteins contain the DDE 
motif, and the human Argonautes that lack it do not form cleavage competent 
RISC (Liu et al., 2004). Some Argonaute proteins contain a central MC domain 
that is very similar to the cap-binding domain of eIF4E. The MC domain of human 
Argonaute 2 (hAGO2) binds to the 5ʼ cap of an mRNA, and this interaction aids in 
repression, possibly by interfering with the eIF4E- 5ʼ cap interaction. hAGO2 
F2V2 mutant proteins can no longer bind the 5ʼ cap, and thus fail to repress 
translation (Kiriakidou et al., 2007). In Drosophila, the only Argonaute that 
contains the MC domain is Argonaute 1 (AGO1). In contrast to the human 
ortholog, Drosophila AGO1 F2V2 mutants are defective in repression, but can 
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still bind the 5ʼ cap. Instead, AGO1 F2V2 mutants lose the ability to bind GW182, 
another component of RISC (Eulalio et al., 2008). 
GW182 
Since its discovery in human cells, GW182 has been identified as an 
evolutionarily conserved gene, essential for development in many organisms 
(Eystathioy et al., 2002; Schneider et al., 2006; Ding et al., 2005). In Drosophila, 
mutants of the GW182 ortholog gawky are lethal. gawky mutants are pleiotropic, 
affecting the earliest stage of development observed, zygotic cellularization 
(Schneider et al., 2006). In C. elegans, mutants of the ortholog ain-1 cause 
defects in developmental timing (Ding et al., 2005).  
GW182ʼs name is derived from properties of the human ortholog: 182 kDa 
in size with a large number of glycine and tryptophan repeats (GW repeats) 
(Eystathioy et al., 2002). GW182 contains a number of protein domains important 
for its function. The N-terminus of GW182 binds to AGO1, while the mid and C-
terminal GW repeats are required for translational repression. Localization of 
GW182 to cytoplasmic puncta requires the Q/N domain, which is also 
responsible for the cytoplasmic localization of AGO1 (Eulalio et al., 2009). 
GW182 localizes to cytoplasmic foci distinct from cytoplasmic organelles, 
called P-bodies (Eystathioy et al., 2002; Eystathioy et al., 2003; Sen and Blau, 
2005; Ding et al., 2005; Behm-Ansmant et al., 2006). P-bodies are sites of mRNA 
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metabolism, where some translational repressors and mRNA decay factors are 
localized (Sheth and Parker, 2003; Teixeira et al., 2005). In some cases, GW182 
is essential for P-body formation (Yang et al., 2004). In addition to its localization 
in P-bodies, GW182 also localizes to endosomes and multivesicular bodies 
(Gibbings et al., 2009; Lee et al., 2009). 
MIRNA-MEDIATED REGULATION 
miRNAs regulate mRNAs by inhibiting different steps of translation.  
Inhibition of translation initiation is proposed to occur through a couple of 
mechanisms. For some mRNAs, a 5ʼ cap is necessary for it to be regulated by 
miRNAs. If the requirement for a 5ʼ cap is bypassed, then miRNA-mediated 
regulation of the transcript is relieved (Pillai et al., 2005; Humphreys et al., 2005; 
Kiriakidou et al., 2007; Mathonnet et al., 2007). This suggests that miRNA 
mediated regulation interferes with the ability of the translation initiation 
machinery to recognize the 5ʼ cap. Inhibition of translation initiation is also 
proposed to occur by blocking the formation of the 80S ribosomal complex. This 
is thought to occur through RISCs association with eIF6, which associates with 
the 60S ribosomal subunit, blocking formation of the 80S ribosome 
(Chendrimada et al., 2007). 
There are a number of examples demonstrating that miRNA-mediated 
repression also affects a post-initiation step of translation (Olsen and Ambros, 
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1999; Nottrott et al., 2006; Petersen et al., 2006). In some cases, reporter 
transcripts repressed by miRNAs are associated with actively translating 
polysomes, while no protein is actively made (Nottrott et al., 2006). In addition, 
some transcripts that initiate translation through an IRES sequence can be 
regulated by miRNAs, suggesting that regulation occurs after translation initiation 
(Petersen et al., 2006). How this mechanism of regulation occurs is unknown. 
miRNA-mediated regulation can cause transcript deadenlyation and 
degradation. Degradation of transcripts regulated by miRNAs occurs in many 
organisms, and can be important for regulation. Transcript degradation occurs in 
zebrafish, where miR-430 targets a number of maternal mRNAs for destruction, 
and in C. elegans, where regulation by let-7 and lin-4 can result in transcript 
degradation (Giraldez et al., 2006; Bagga et al., 2005). In Drosophila, the 
CCR4:NOT1 complex deadenylates transcripts regulated by miRNAs, while the 
DCP1:DCP2 decapping complex removes the 5ʼ cap of these transcripts (Behm-
Ansmant et al., 2006; Eulalio et al., 2008b). Although removal of the poly(A) tail 
occurs for many regulated transcripts, it is not required for miRNA-mediated 
repression; reporter mRNAs lacking a poly(A) tail are still repressed (Huntzinger 
et al., 2008; Eulalio et al,. 2008).  
  P-bodies were once thought to be sites where miRNA-mediated regulation 
occurred (Liu et al, 2005). In mammalian cells, transcripts regulated by miRNAs, 
along with components of RISC, localize to P-bodies (Liu et al., 2005a; Liu et al., 
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2005b). Despite this localization, miRNA-mediated regulation does not require 
the presence of microscopic P-bodies, although a number of P-body components 
are required for some aspects of regulation (Eulalio et al., 2007). Transcripts 
regulated by miRNAs may enter P-bodies to be degraded or stored for future use.  
In Drosophila and human cells, transcripts repressed by miRNAs can leave P-
bodies and re-enter the translating pool of mRNAs when the cell requires them 
(Bhattacharyya et al., 2006; Ashraf et al., 2006). Recently, endosomes and 
multivesicular bodies have been implicated in miRNA-mediated repression.  
miRNAs, Argonaute proteins, and GW182 localize to endosomes and 
multivesicular bodies, raising the possibility that these structures are sites where 
miRNA-mediated repression can occur (Lee et al., 2009; Gibbings et al., 2009).   
OVERVIEW OF THE DISSERTATION RESEARCH 
There are two major aims in this thesis: to identify the function of the osk 
mRNA during oogenesis, and to characterize miRNA mediated regulation in 
Drosophila.   
The osk 3ʼ UTR is essential for egg chamber progression through 
oogenesis. Its precise function for progression through oogenesis is unknown, 
but two models have been proposed: the osk 3ʼ UTR acts as a scaffold that forms 
an RNP complex required during oogenesis, or the osk 3ʼ UTR sequesters a 
regulator that, when not bound to the osk mRNA, inhibits oogenesis (Jenny et al., 
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2006). Both of these models require a factor bound to the osk 3ʼ UTR. Bru binds 
to the well-defined BRE sequences in the osk 3ʼ UTR (Kim-Ha et al., 1995; 
Webster et al., 1997; Lie and Macdonald, 1999), and is therefore a potential 
candidate for this factor. To test whether Bru is this factor, we monitored the osk 
RNA null arrest of oogenesis using genomic osk constructs that contained wild 
type BREs or mutant BREs. We discovered that the osk RNA BREs are essential 
for their function in egg chamber progression through oogenesis. In addition, 
through expression of exogenous BREs in egg chambers, and decreasing aret 
gene dosage, we determined that sequestration of Bru is necessary for egg 
chamber progression through oogenesis.  Our results suggest a novel regulatory 
loop where the osk mRNA binds and sequesters Bru, preventing Bru from 
misregulating mRNAs, and in turn, Bru binding to the osk BREs regulates the 
translation of the osk mRNA. 
To investigate miRNA-mediated regulation in Drosophila, we first looked at 
miRNA-mediated regulation in the ovary. An ovarian assay system was 
developed consisting of a GFP reporter transcript that is regulated by miR-312, 
an ovarian expressed miRNA. Regulation of the GFP reporter occurred at the 
level of translational repression, rather than mRNA degradation. In addition, the 
distribution of transcripts repressed by miRNAs, and AGO1, were distinct from 
the P-body components Dcp1 and Me31B.  
 17 
To identify genes involved in miRNA-mediated regulation, we took a 
forward genetics approach and devised an assay that allowed the use of a 
simple screen to identify mutants with defects in miRNA-mediated gene 
regulation. We identified a number of mutants that affected repression using this 
assay. The genomic regions of two genes isolated from the screen were mapped 
to different regions consisting of about one million nucleotides each. Both 
genomic regions are devoid of genes currently implicated in miRNA-mediated 
regulation, suggesting that our mutants identify novel components of this 
pathway. 
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Chapter 2: miRNA-mediated regulation in the Drosophila Ovary1 
ABSTRACT 
 
The Drosophila ovary is a tissue rich in post-transcriptional regulation of 
gene expression. Many of the regulatory factors are proteins identified via genetic 
screens. The more recent discovery of microRNAs, which in other animals and 
tissues appear to regulate translation of a large fraction of all mRNAs, raised the 
possibility that they too might act during oogenesis. However, there has been no 
direct demonstration of microRNA-dependent translational repression in the 
ovary. Here, quantitative analyses of transcript and protein levels of transgenes 
with or without synthetic miR-312 binding sites show that the binding sites do 
confer translational repression. This effect is dependent on the ability of the cells 
to produce microRNAs. By comparison with microRNA-dependent translational 
repression in other cell types, the regulated mRNAs and the protein factors that 
mediate repression were expected to be enriched in sponge bodies, subcellular 
structures with extensive similarities to the P-bodies found in other cells. 
However, no such enrichment was observed. Our results reveal the variety of 
post-transcriptional regulatory mechanisms that operate in the Drosophila ovary, 
                                                
1 A large portion of this work was published in PLoS ONE (2009), 4: e4669 
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and have implications for the mechanisms of miRNA-dependent translational 
control used in the ovary.  
INTRODUCTION 
  
 Small regulatory RNAs act in a wide range of processes that contribute to 
control of gene expression. In eukaryotes, three classes of such RNAs have 
been characterized most extensively. Small interfering RNAs (siRNAs) mediate 
RNA interference or silencing, in which target mRNAs are degraded. microRNAs 
(miRNAs) are identical in structure to siRNAs, but have different origins and 
processing. miRNAs regulate protein accumulation from target mRNAs by a 
variety of mechanisms. Repeat associated small interfering RNAs (rasiRNAs) are 
synthesized through yet another pathway, and function in both chromatin 
organization and mRNA degradation. Each class of small RNA acts in 
conjunction with a protein complex consisting of an Argonaute family member 
and associated proteins: the RNA provides specificity through base pairing, either 
complete or incomplete, with targets, and the proteins act as effectors by various 
mechanisms that in most cases are not yet fully understood (Bartel, 2004). 
 Oogenesis in Drosophila is a developmental context rich in post-
transcriptional control of gene expression (Lipshitz and Smibert, 2000). Not 
surprisingly, small RNAs are active in this setting. The most extensive evidence 
 30 
is available for the rasiRNA pathway, for which the Argonaute proteins are Piwi, 
Aubergine (Aub) and AGO3. The Piwi and Aub proteins have well-established 
roles during oogenesis in controlling stem cell divisions and in the events leading 
to formation of the embryonic germ line cells, but the details of their modes of 
action were not well understood (Cox et al., 2000; Harris and Macdonald, 2001; 
Wilson et al., 1996). More recently, Piwi, Aub and AGO3 have been found to 
associate with rasiRNAs, and piwi and aub mutants (no AGO3 mutants have 
been described) are defective in the rasiRNA dependent silencing of various 
retrotransposons (Saito et al., 2006; Vagin et al., 2006; Gunawardane et al., 
2007; Brennecke et al., 2007; Chen et al., 2007). A number of genes have been 
implicated in the production of rasiRNAs; mutation of any of these genes results 
in deregulation of the transposons (Vagin et al., 2006; Pane et al., 2007; Lim and 
Kai, 2007). 
 siRNAs were the first small regulatory RNAs shown to be active during 
oogenesis, but with limitations on when they can function. Late stage oocytes do 
not support RNA interference. However, this pathway is activated during egg 
activation, and introduction of exogenous dsRNAs results in degradation of target 
mRNAs (Kennerdell et al., 2002). Early in oogenesis the RNA interference 
pathway alters expression of oskar (osk) mRNA, apparently via indirect effects on 
the cytoskeleton (Cook et al., 2004).  It is not known why this pathway is not 
active throughout all of oogenesis. AGO2, the Argonaute protein that acts in 
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RISC, the RNP complex that mediates RNA interference (Okamura et al., 2004), 
is present for all the stages of oogenesis when immunodetection is possible (i.e., 
prior to deposition of the vitelline membrane), but whether it is present in the late 
stage oocytes that do not support RNA interference is unknown (Brennecke et 
al., 2007; Findley et al., 2003).  
 Indirect evidence suggests that there will be miRNA-dependent control of 
translation in the ovary. Multiple miRNAs are present at high levels in early stage 
embryos, when zygotic transcription has not yet begun, and so these should 
have been provided maternally as a consequence of synthesis in the ovary 
(Aravin et al., 2003).  Furthermore, several miRNAs have been directly shown to 
be present in the ovary (Saito et al., 2006).  A second line of indirect evidence 
comes from characterization of AGO1 mutants. AGO1 is the Argonaute protein 
that acts in the miRNP, the RNP complex that mediates miRNA-dependent 
translational control (Okamura et al., 2004).  Mutation and overexpression of 
AGO1 each affect, with opposite consequences, the fate of germline stem cells, 
leading to the proposal that the miRNA pathway acts in this process (Yang et al., 
2007).  However, the roles of different AGO proteins can overlap (Meyer et al., 
2006).  The roles of AGO1 and AGO2 were defined in cultured Drosophila S2 
cells (Okamura et al., 2004), and evidence that a particular protein has one role 
in one tissue does not necessarily mean that it will do the same in all other 
settings. The possibility of miRNA control in the germ line cells of the ovary was 
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also raised by a peculiar feature of osk mRNA regulation. Specifically, in certain 
mutants with drastically reduced levels of Osk protein, a large fraction of osk 
mRNA is present in polysomes (Braat et al., 2004).  Such a phenomenon – 
polysome association of mRNAs not directing the accumulation of the encoded 
protein – is a feature of some mRNAs under miRNA control (Bartel, 2004), 
although other regulatory pathways have the same effect (Rajavel and Neufeld, 
2001).  
 If miRNA-dependent translational control does operate in the ovary, then the 
site or sites at which the regulation occurs will be of interest, and may provide 
information about possible mechanisms. At present, the mechanism of miRNA-
dependent translational repression is a subject of controversy. Some studies 
have pointed to miRNAs intervening after the initiation of translation, which, as 
noted above, results in association with polysomes without protein accumulation 
(Maroney et al., 2006; Nelson et al., 2004; Nottrott et al., 2006; Petersen et al., 
2006).  Other analyses have revealed an effect of miRNAs on initiation of 
translation (Pillai et al., 2005; Humphreys et al., 2005; Kiriakidou et al., 2007; 
Chendrimada et al., 2007).  The latter option fits well with observed sites of 
miRNA regulation, in P-bodies. P-bodies were initially identified, in yeast, as 
RNPs containing mRNAs destined for degradation (Brengues et al., 2005; 
Teixeira et al., 2005).  More recently, mammalian P-bodies have been found to 
contain mRNAs under miRNA control, as well as AGO proteins and other 
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proteins required for the action of miRNAs (Pillai et al., 2005; Chu and Rana, 
2006; Sen and Blau, 2005).  Furthermore, in cultured Drosophila cells P-body 
formation has been shown to be a consequence of RNA-mediated gene 
silencing, whether by AGO1- or AGO2-dependent pathways (Eulalio et al., 2007).  
P-bodies lack ribosomes (Teixeira et al., 2005), and so an mRNA under miRNA 
repression could not be in P-bodies if it is associated with polysomes. In the 
germline cells of the Drosophila ovary there appear to be no conventional P-
bodies, but instead a higher order structure known as sponge bodies. Sponge 
bodies were first described as cytoplasmic sites at which the Exuperantia (Exu) 
protein, which acts in mRNA localization, is highly concentrated (Wilsch-
Brauninger et al., 1997).  Subsequently, a number of other proteins with roles in 
post-transcriptional control of gene expression have been shown to colocalize 
with Exu (Wilhelm et al., 2000; Nakamura et al., 2001; Styhler et al., 2002; 
Wilhelm et al., 2003; Nakamura et al., 2004; Lin et al., 2006; Delanoue et al., 
2007).  Notably, the sponge body proteins include homologs of multiple P-body 
components, and sponge bodies are largely devoid of ribosomes (Wilsch-
Brauninger et al., 1997).  Sponge bodies and P-bodies do not appear to be 
equivalent, as sponge bodies include cisternae and vesicles while no membrane 
is found in the P-body-like GW182 bodies (there have been no ultrastructural 
studies of P-bodies) (Wilsch-Brauninger et al., 1997; Yang et al., 2004).  
However, it does seem likely that sponge bodies represent a membrane-based 
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framework upon which RNPs similar or equivalent to P-bodies are positioned. By 
analogy to mammalian cells and to cultured Drosophila cells, these sponge body 
RNPs would be an expected site of miRNA action. 
 Here we directly test for miRNA-dependent translational repression in the 
ovary, and find that it does occur. We also show that there is no detectable 
concentration of repressed mRNAs with sponge bodies. Instead, the regulated 
mRNAs are present in numerous very small cytoplasmic particles. Both AGO1 
and AGO2 (or GFP fusions to these proteins) appear in similar small particles. 
These results do not rule out any specific model for the mechanism by which 
miRNAs repress translation in the ovary, but do allow for translational inhibitory 
mechanisms that act after initiation of translation. 
RESULTS 
 To test for miRNA activity in the Drosophila ovary we focused on miR-312. 
Northern blot analysis of miRNAs during embryogenesis has revealed that miR-
312 is present at the highest levels in 0-1 hour embryos, suggesting that it is 
expressed during oogenesis (Aravin et al., 2003).  Indeed, miR-312 expression in 
the ovary has been detected by a PCR assay (Neumuller et al., 2008). We 
confirmed the ovarian expression of miR-312 by in situ hybridization. A Locked 
Nucleic Acid probe for miR-312 reveals the miRNA to be present throughout the 
ovary, in both germ line cells (nurse cells and the oocyte) and somatic follicle 
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cells (Fig. 2.1A). By contrast, a probe with a scrambled sequence shows no -
hybridization (Fig. 2.1B). 
 To monitor potential miR-312 repressive activity, a GFP reporter assay was 
developed. Six tandem copies of a synthetic miR-312 binding site were added to 
the 3' UTR of a UAS-GFP transgene (Fig. 2.1C). The binding sites were 
designed to allow incomplete base pairing with miR-312, such that the 5ʼ ʻseedʼ 
and 3ʼ regions of the miRNA would be fully base paired, with a central unpaired 
bulge (Fig. 2.1D). Interrupted base pairing of this type usually leads to 
translational repression by miRNAs, rather than RNA degradation (Doench et al., 
2003; Doench et al., 2004; Saxena et al. 2003).  Multiple copies of the miR-312 
binding sites were used to increase the probability of efficient miR-312 binding. 
Although no confirmed targets of miR-312 action have been identified, the 
ovarian kelch mRNA is a candidate with 4 predicted miR-312 binding sites 
(Burgler and Macdonald, 2005). Transcription of the reporter transgene relies on 
the UAS component, which responds to the GAL4 transcriptional activator (Brand 
and Perrimon, 1993; Rorth, 1998).  Following expression of the reporter (UAS-
GFP-312) and control (UAS-GFP) transgenes in the germline cells of the ovary 
using the matalpha4-GAL-VP16 driver, GFP protein and mRNA levels were 
measured by quantitative western blot analysis and quantitative real time PCR 
(RT-PCR). The transgene with miR-312 sites produces significantly less GFP 
than the control transgene (Fig. 2.1E). This difference can be attributed in part, 
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but not in whole, to unequal mRNA levels: the mRNA with miR-312 targets is 
present at 70% of the level of the control transgene (Fig. 2.1E). Normalization for 
the different mRNA levels reveals that the GFP -312 mRNA is about half as 
active as the control GFP mRNA in production of GFP protein (Fig. 2.1E). Thus, 
the presence of the miR-312 target sites in the GFP-312 mRNA confers 
translational repression.  
 As an additional assay of miRNA activity, a second set of transgenes was 
constructed and tested. The UAS-osk control transgene is similar to UAS-GFP, 
except that the coding region is now from an osk cDNA (with none of the osk 3ʼ 
UTR). UAS-osk-312 differs from UAS-osk by the addition of four tandem copies 
of the synthetic miR-312 binding site. When expressed in the ovary using the 
matalpha4-GAL-VP16 driver, the UAS-osk control transgene produces ectopic 
Osk, which disrupts anterior embryonic body patterning resulting in a very high 
frequency of bicaudal embryos (96%; n=131)(Fig. 2.1G). In contrast, expression 
of the UAS-osk-312 transgene with the miR-312 binding sites has no significant 
effect on embryonic patterning: the vast majority of embryos (94%; n=373) 
appear wild type (Fig. 2.1F). Both transgene mRNAs are present at similar levels 
(Fig. 2.1H). Thus, in each of two assays the addition of miR-312 binding sites to 
an mRNA leads to its translational repression. 
 Translational repression of the reporter mRNAs could be due to the action of 
miRNAs, or could arise in some other manner because of the addition to the 
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reporter mRNA of the sequences that make up the miR-312 binding sites. To 
distinguish between these options we asked if miRNAs are required for the 
observed repression of the GFP reporter mRNA. Loquacious (Loqs) protein acts 
in processing pre-miRNAs, and loqs mutants are defective in this process 
(Forstemann et al., 2005).  In loqs mutant ovaries the level of GFP produced from 
the UAS-GFP-312 transgene was elevated about 2x relative to loqs/+ 
heterozygotes, while mRNA levels did not show a corresponding increase (Fig. 
2.2A). This change in protein level corresponds well to the observed level of 
translational repression, and demonstrates that repression is dependent on 
miRNAs.  
 GFP levels in individual egg chambers were also examined by confocal 
microscopy. Comparison of ovaries expressing either the GFP or GFP-312 
mRNAs reveals two differences. First, the overall GFP level was typically lower 
from the mRNA with the miR-312 targets, consistent with the quantitative western 
blot analysis. Second, GFP levels dropped at later stages for the GFP-312 
mRNA, but not for the GFP mRNA (Fig. 2.2B,C). To quantify this effect GFP 
levels were measured at different stages of oogenesis within individual ovarioles: 
at stage 7/8 (before the reduction) and at stage 10. Of the ovarioles expressing 
GFP-312 mRNA, greater than 75% showed at least a 1.5 fold reduction in GFP at 
the later stage, while less than 5% of ovarioles expressing GFP mRNA showed 
such a reduction (Fig. 2.2D). 
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 Although the quantitative measures of mRNA and protein levels for the 
reporter transgenes clearly demonstrate an effect at the level of protein 
accumulation, it remains possible that miR-312 is also affecting the stability of the 
reporter mRNA. Because the reporter and control mRNAs are expressed from 
different transgenes, the site of transgene insertion might influence transcription 
(transgenes under UAS/GAL4 control do show some line-to-line variability in 
expression levels). Thus we cannot readily determine if the differences in levels 
for the GFP-312 and GFP mRNAs are due to the action of miRNAs. However, it 
is simple to determine if the late stage reduction in GFP translated from the GFP-
312 mRNA is accompanied by a reduction in transcript levels. For both GFP and 
GFP-312 mRNAs there is a substantial increase in mRNA levels later in 
oogenesis, rather than a decrease (Fig. 2.2E,F), consistent with the known 
activity of the GAL4 driver used for expression (Martin and St Johnston, 2003).  
Why the GFP-312 mRNA is more effectively repressed at later stages of 
oogenesis is uncertain. The levels of miR-312 RNA appear to increase during 
this period (Fig. 2.1A), but attempts to use fluorescent-based in situ hybridization 
to obtain more quantitative data that would address this possibility have not been 
successful. 
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SITES OF MIRNA ACTIVITY IN THE OVARY  
 Having demonstrated that miRNA-dependent translational repression does 
occur in the ovary, we wished to ask if the repressed mRNAs and factors 
involved in repression are concentrated in sponge bodies.  
 In one line of experiments the distributions of Argonaute family members were 
monitored, either by live imaging of GFP fusion proteins or by immunodetection 
in fixed samples. For live imaging a Me31B::GFP fusion protein was used to 
mark sponge bodies, and AGO1::GFP and AGO2::GFP distributions were 
evaluated. In other tissues AGO1 is primarily responsible for miRNA-mediated 
translational repression, while AGO2 acts in RNA interference (Okamura et al., 
2004).  In the ovary both AGO proteins are predominantly cytoplasmic, with much 
lower levels in the nuclei. This pattern is strikingly distinct from the characteristic 
sponge body distribution seen with the Me31B::GFP marker. Sponge bodies are 
also cytoplasmic, but are concentrated in discrete large domains (Fig. 2.3A).  
 At higher magnification, the distribution of both AGO1::GFP and AGO2::GFP 
can be seen to be punctate, with the proteins appearing in many small foci (Fig. 
2.3B,C). This distribution is not characteristic of GFP fusion proteins (Morin et al., 
2001).  Moreover, the distribution is distinctly different from that of GFP alone, 
which is more uniform in the cytoplasm (Fig. 2.3D). As a quantitative measure of 
the difference between the patterns of GFP and the AGO::GFP fusion protein 
distributions, we evaluated the range of fluorescence intensities. A uniform 
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protein distribution in a given field should show a narrow range of fluorescence 
intensity. In contrast, a protein that is concentrated in particles should show a 
broader range of intensities: low outside of the particles, and high in the particles. 
Fluorescence intensities were assigned colors in a look up table (LUT)(see Fig. 
2.3 legend). The variation in fluorescence intensity is much greater for 
AGO1::GFP and AGO2::GFP than for GFP (Fig. 2.3Bʼ-Cʼ). This variation confirms 
that both AGO fusion proteins are concentrated at many small foci. In a direct 
comparison of protein distributions by immunostaining of fixed egg chambers, 
AGO1 was detected in tiny foci similar in number and distribution to those 
detected with AGO1::GFP in live samples (Fig. 2.3E), while Bruno (Bru; a sponge 
body component; Snee et al., 2008; Snee and Macdonald, 2009) was largely 
non-overlapping and predominantly in the much larger sponge bodies (Fig. 2.3F). 
Similarly, the Drosophila ortholog of Dcp1, a component of P-bodies in other 
organisms (Cougot et al., 2004, J Cell Biol, 165, 31-40; Sheth and Parker, 2003, 
Science, 300, 805-808) and of sponge bodies in the Drosophila ovary (Lin et al., 
2006, Dev Cell, 10, 601-13), was found in sponge bodies but not in the AGO1-
positive puncta (Fig. 2.3H). 
 Knowledge of the AGO protein distribution in the egg chamber provides useful 
but nevertheless limited information about the sites of miRNA mediated 
repression. The absence of any enrichment of AGO1 and AGO2 proteins (or 
GFP fusions of these proteins) in sponge bodies suggests that sponge bodies 
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are not the primary destination for mRNAs under miRNA control. The many small 
foci of AGO proteins in the cytoplasm are good candidates for sites of repression. 
However, it is also possible that the lower level of more uniformly distributed 
AGO proteins comprise the fraction actively engaged in regulation. We therefore 
took another approach to more directly monitor sites of miRNA action in the 
ovary.  
 Using a tethering assay, control mRNAs and mRNAs under miRNA 
repression were tracked in live samples. In this type of assay, a fusion protein 
consisting of an RNA binding domain and GFP is tethered to an mRNA bearing 
the appropriate RNA binding sites (Bertrand et al., 1998).  We used an MS2 coat 
protein::GFP (MCP::GFP) fusion protein previously shown to work in this assay in 
Drosophila egg chambers (Forrest and Gavis, 2003), together with UAS-osk 
reporters as described above (the UAS-GFP type of reporter transgene could not 
be used, as expression of GFP from the reporter would create a high background 
that would interfere with specific detection of the tethered MCP::GFP). In the 
absence of any transcripts with the MS2 binding sites, the MCP::GFP protein is 
largely nuclear (Fig. 2.4A) as it contains a nuclear localization signal (NLS). 
However, when reporter transcripts with MCP binding sites (with or without miR-
312 target sites) are also present, the MCP::GFP adopts a new distribution: it is 
now predominantly cytoplasmic (Fig. 2.4B,C). The shift to the cytoplasm 
presumably results from nuclear export of reporter mRNAs. Bound molecules of 
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MCP::GFP are thus moved into the cytoplasm, reducing the fraction of 
MCP::GFP in the nuclei. The UAS/GAL4 expression system allows for high levels 
of transcription, and it is therefore not surprising that the reporter transcripts can 
influence the balance of MCP::GFP between the nucleus and cytoplasm.  
 Within the cytoplasm the tethered reporter mRNAs, both regulated and 
unregulated, are present in very small particles distributed in very similar patterns 
(Fig. 2.4A,B). In contrast, MCP::GFP in the absence of reporter transcripts is 
more evenly distributed (Fig. 2.4A). The reporter transcripts do not appear in 
large puncta, indicating that they, like the AGO proteins, are not enriched in 
sponge bodies. As a more direct demonstration of this property, the sponge body 
component Bru was detected simultaneously with MCP::GFP in fixed samples of 
these ovaries. No concentration of the tethered reporter mRNAs in the Bru-
containing sponge bodies was detected (Fig. 2.4D).  
 The patterns in which AGO proteins and regulated and unregulated reporter 
transcripts are distributed are indistinguishable. This similarity could simply 
indicate that each molecule is found in many small RNP particles that are 
dispersed throughout the cytoplasm. If the foci of transcripts under miRNA 
regulation do correspond to sites of repression, then they might be expected to 
be coincident with the foci of AGO1 protein. We tested this prediction by double 
labeling. Notably, there is very little overlap in the two types of foci (Fig. 2.4E). 
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DISCUSSION 
  Evidence presented here addresses the possibility that miRNA dependent 
control of gene expression occurs in the Drosophila ovary. The miRNA miR-312 
is expressed during oogenesis, and addition of synthetic miR-312 binding sites to 
either of two different reporter mRNAs reduces their activities. This effect is 
dependent on the ability of the ovary to synthesize miRNAs. Collectively, these 
results make a compelling case for activity of miRNAs in the ovary. Furthermore, 
the data show that the stages when miRNA dependent regulation occurs include 
the mid to late stages of oogenesis, when post-transcriptional control of gene 
expression plays a crucial role in the events that lead to patterning of the embryo. 
Thus, miRNAs have the potential to contribute to this process.  
 Although we have focused only on a single miRNA, many of the known 
miRNAs are present at high levels in early stage embryos that have not initiated 
zygotic transcription (Aravin et al., 2003), and these miRNAs should also be 
present in the ovary. Our evidence shows that the miRNA machinery is 
competent for function during oogenesis, and it would be very unlikely that only 
miR-312 can make use of that machinery. Thus, there is every expectation that in 
oogenesis numerous miRNAs are actively engaged in regulation and many 
mRNAs are regulated by miRNAs. 
 To address the question of where in the ovary miRNA-mediated translational 
repression occurs, we monitored the distribution of AGO proteins and reporter 
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mRNAs under miRNA control. Using high resolution confocal microscopy and 
detection either by immunofluorescence in fixed ovaries or live imaging of an 
AGO1::GFP fusion, we find that AGO1 is present in many small foci rather than 
being uniformly dispersed throughout the cytoplasm. A similar pattern is 
observed for reporter mRNAs detected by indirect labeling with tethered GFP, 
independent of whether they are under miRNA control. The AGO1-containing foci 
are distinct from those containing the regulated reporter mRNAs. Thus, the 
significance of the small foci remains uncertain.  
 The main conclusion of this portion of our work is that sponge bodies are not 
the primary sites of miRNA activity. Notably, neither AGO1 nor the repressed 
mRNAs display any detectable concentration in sponge bodies (see also Findley 
et al., 2003).  Sponge bodies are similar to P-bodies, with many shared 
components (Wilhelm et al., 2000; Nakamura et al., 2001; Styhler et al., 2002; 
Wilhelm et al., 2003; Nakamura et al., 2004; Lin et al., 2006; Delanoue et al., 
2007).  In some other cell types P-bodies are enriched in miRNP components, 
and can readily be seen as bright foci on a darker background when either 
miRNP protein components or regulated mRNAs are detected with fluorescent 
labels (Pillai et al., 2005; Sen and Blau, 2005; Liu et al., 2005).  This enrichment 
initially suggested that a major fraction of the miRNP components are in P-
bodies. However, subsequent quantitative analyses revealed that only a very 
small fraction (less than 2%) of the miRNP AGO protein is in the P-bodies, and 
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that the vast majority of the protein is in the cytoplasm but diffuse and therefore 
more difficult to detect (Leung et al., 2006).  By way of comparison, then, our 
failure to detect any enrichment of AGO1 or transcripts under miRNA control in 
sponge bodies indicates that the fraction present must be substantially less than 
the 2% of the cited example; in effect there can be essentially no enrichment at 
all.  
 The distribution of miRNPs within the cell is relevant to the mechanism by 
which translation is repressed by miRNAs. P-bodies lack ribosomes, and the 
presence of certain miRNPs and their regulated mRNAs within P-bodies 
indicates that these mRNAs are not undergoing translation. This fits well with 
some models for miRNA-dependent repression, in which the initiation of 
translation is inhibited (Pillai et al., 2005; Humphreys et al., 2005; Kiriakidou et 
al., 2007; Chendrimada et al., 2007).  There is also evidence for regulation by 
miRNAs after initiation of translation, with the repressed mRNAs being 
associated with polysomes (Maroney et al., 2006; Nelson et al., 2004; Nottrott et 
al., 2006; Petersen et al., 2006).  Obviously, such a mechanism could not apply 
for the mRNAs found in P-bodies. Consequently, any enrichment of miRNPs in 
sponge bodies (whose similarity with P-bodies includes an almost complete lack 
of ribosomes (Wilsch-Brauninger et al., 1997), would be consistent with 
repression blocking initiation of translation. The observed absence of such an 
enrichment raises the possibility that whatever mechanism delivers miRNPs to 
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the P-bodies is not operating in the germline cells of the ovary (where the sponge 
bodies are found), at least for the developmental stages examined. While this 
does not rule out miRNA-dependent translational repression at the level of 
initiation, it does leave open the possibility that action of miRNAs after initiation of 
translation may be more prominent in this setting than in cells with conventional 
P-bodies. 
MATERIALS AND METHODS 
Plasmids 
 UAS-GFP (p8508) is pUASp (Rorth) to which mGFP6 (Haseloff, 1999) has 
been introduced as an Asp718 fragment into the Asp718 site. The mGFP6 
Asp718 fragment begins with 
GGTACCCAATTCGTTAACAGATCCAAGGAGATATAACA prior to the mGFP6 
start codon, and ends with CTCGAGGGTACC after the mGFP6 stop codon. A 
synthetic single miR-312 binding site cassette was constructed by PCR and had 
the sequence 5ʼTCTAGATCAGGCCGTAGAAGTGCAATACTAGT 3ʼ. This 
cassette, which includes XbaI and SpeI sites at the 5ʼ and 3ʼ ends, was 
multimerized using the XbaI and SpeI sites. A 6x version was inserted into the 
XbaI site of UAS-GFP to make UASp-GFP-312 (p8701). A 4x version of the miR-
312 binding sites was introduced into the XbaI site between the osk coding 
region and UASp vector 3ʼ UTR of UAS-osk (Snee and Macdonald, 2004) to 
 47 
make UAS-osk-312 (p8619). UAS-osk-312 was further modified by addition of 16 
copies of the MS2 coat protein binding site to the 3' UTR (Bertrand et al., 1998) 
to make UAS-osk-312-MS2 (p8492). UAS-osk was modified in the same manner 
to make UAS-osk-MS2 (p8516).  
Fly strains 
 loqsf00791 flies were from Bill Theurkauf. Transgenes constructed in this 
study were injected by Genetic Services, Inc. GFP trap stocks were the following: 
AGO1CA06914; AGO2CA07002; and ME31B::GFP  (Morin et al., 2001; Buszczak et al, 
2007). The latter GFP trap was recovered from stock ZCL1796, which was 
described as having an insertion that tags CG3634 on the third chromosome. 
Molecular characterization of this stock revealed that the GFP fluorescence from 
this line was entirely from a second GFP trap insertion in the me31B gene. 
MS2::GFP was from E. Gavis. The expression of UAS transgenes was driven by 
the matalpha4-GAL-VP16 driver (Martin and St Johnston, 2003). YFP::dDcp1 
was from Tze-Bin Chou (Lin et al., 2006). 
Real-time RT PCR 
RNA was isolated from dissected ovaries using Tri Reagent-LS according 
to the manufacturers instructions (Molecular Research Center). 2 µg of ovarian 
RNA was reverse transcribed using random primers and the High Capacity cDNA 
Reverse Transcription kit (Applied Biosystems). Real-time PCR was performed 
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using the 7900HT Sequence Detector and the Power SYBR Green PCR Master 
Mix (Applied Biosystems). mRNA levels were determined by relative quantitation 
with a standard curve and normalized to RpL32 mRNA. All experiments were 
performed at least 3 times. Primers to amplify cDNAs were the following: GFP, 
TTTTCGTTGGGATCTTTCGAA and ACGGCGGCGTGCAAC; RpL32, 
GCGCACCAAGCACTTCATC and GACGCACTCTGTTGTCGATACC; osk, 
GCGTTAGGTCCTGTTCATTGGT and GCCATCGCTTGGAGGAAAG. 
Quantitative western analysis 
 Ovaries were collected on ice and homogenized in SDS-PAGE loading 
buffer with protease inhibitors (5 mM benzamidine and 10 µM PMSF). Samples 
were boiled for 5 minutes and loaded on a SDS-PAGE gel. Western blots were 
performed using the LI-COR detection system according to the manufacturers 
instructions and imaged using a Odyssey Infrared Imaging System (LI-COR 
Biosciences). GFP protein levels were normalized relative to ß-tubulin. All 
experiments were performed at least 3 times. Anti-GFP antibodies were prepared 
by Josman Laboratories. ß-tubulin was detected with monoclonal antibody E7 
from the Developmental Studies Hybridoma Bank. 
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In-situ hybridization 
 To detect miR-312, a digoxigenin labeled Locked Nucleic Acid probe 
(TATTGCACTTGAGACGGCCTGA)(Exiqon) was used according to the 
manufacturers instructions with annealing temperature of 55oC. The sequence of 
the scrambled control probe is TTCACAATGCGTTATCGGATGT. To detect GFP 
mRNA, an antisense probe was prepared by in vitro transcription and labeled 
with digoxigenin. Hybridization and detection were performed as described 
(Buszczak et al., 2007) except that the first wash following hybridization was 
raised 3 degrees C (relative to the hybridization temperature) to reduce 
background. 
Immunofluorescence and microscopy 
 Ovaries were fixed, stained and imaged as described (Snee and 
Macdonald, 2004), except for the analysis of Fig. 2.2, in which ovaries were fixed 
as described (Harris and Macdonald, 2001) and stained with AlexaFluor 594 
phalloidin (Molecular Probes). The area based analysis function of the Leica 
Confocal Software was used to measure the mean GFP fluorescence in the 
nurse cell cytoplasm. Fluorescence in regions of the same size was measured in 
three nurse cells from each egg chamber. Antibodies were used at the following 
dilutions: rabbit anti- AGO1 ab5070 (Abcam), 1/100; rat anti-Bru, 1/500. Live 
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imaging of GFP was performed as described previously (Snee and Macdonald, 
2004). 
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FIGURES 
Figure 2.1. Expression and activity of miR-312 in the ovary.  
A and B. In situ hybridization with locked nucleic acid probes. The probe in A is 
complementary to miR-312, while the probe in B has a scrambled sequence. The 
miR-312 hybridization signal appears throughout these stages of oogenesis 
(levels are very low at the earliest stages of oogenesis, at the extreme left. 
C. GFP reporter transgenes to detect miR-312 activity. The diagrams show the 
transgene mRNAs (not to scale). Transgenes with the osk coding region as the 
reporter are essentially the same, with replacement of the coding regions, except 
that the GFP reporter has 6 copies of the miR-312 binding site while the osk 
reporter has 4 copies. 
D. Sequence of a single copy of the miR-312 synthetic binding site, shown as it 
would base pair to miR-312.  
E. Translational repression of the UAS-GFP-312 reporter transgene. GFP protein 
and mRNA levels were measured by quantitative western blotting and 
quantitative real time PCR, respectively, with levels from the UAS-GFP transgene 
normalized to 1. Averages from 3 or more experiments are shown, with standard 
deviations indicated. Normalization for mRNA levels, at right, reveals the level of 
translational repression per unit of mRNA. Note that the regulated and 
unregulated mRNAs are expressed from different transgenes and that any effect 
of the miR-312 binding sites on mRNA levels can not be addressed in this 
analysis. If the presence of the miR-312 binding sites reduces mRNA levels, as is 
common in cases of miRNA regulation, then the effective degree of negative 
regulation would be even greater. 
F. Wild type cuticle of an embryo from females expressing UAS-osk-312. 
G. Bicaudal cuticle of an embryo from females expressing UAS-osk.  
H. Levels of mRNA from osk reporter transgenes, measured by quantitative real 
time PCR and normalized to 1 for the unregulated UAS-osk transgene mRNA. 
Averages from 3 or more experiments are shown, with standard deviations 
indicated. 
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Figure 2.2. Translational repression of GFP-312 mRNA requires miRNA 
production. 
A. Quantitation of protein and mRNA levels from the UAS-GFP-312 transgene in 
females heterozygous or homozygous for loqsf00791. Levels were determined as 
in Figure 2.1.  
B and C. GFP in ovarioles expressing the UAS-GFP (B) or UAS-GFP-312 (C) 
transgenes. GFP is in green, and phalloidin staining in red. GFP signal intensity 
at early stages of oogenesis (to the left in the panels) is typically lower for the 
UAS-GFP-312 transgene, but was adjusted to show a similar intensity as for 
UAS-GFP at those stages; this better reveals the extent of the difference 
between GFP levels for the two transgenes at later stages of oogenesis (at right).  
D. Quantitation of early/late stage GFP levels in individual ovarioles. 
Fluorescence intensity was measured in stage 7 or 8 and 10 egg chambers of 
individual ovarioles. If the ratio of fluorescence in stage 7/8 to stage 10 was 
greater than 1.5, then the ovariole was considered to show repression. 
E and F. In situ hybridization detection of GFP (E) and GFP-312 (F) mRNAs. 
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Figure 2.3. Subcellular distribution of AGO and AGO::GFP proteins in the 
ovary. 
Panels A-D show the distributions of GFP fusion proteins in the nurse cells of live 
stage 9 egg chambers, with higher magnification images in Aʼ-Dʼ. Scale bars are 
10 µm in A-D and 5 µm in A'-D'. A, Me31B::GFP; B, AGO1::GFP; C, AGO2::GFP; 
and D, GFP. The lower resolution images (with the nuclei marked as N) 
demonstrate the absence of any detectable concentration of either of the 
AGO::GFP fusion proteins in localized regions of the cytoplasm, as would be the 
case if they are enriched in sponge bodies. Sponge body distribution is shown by 
Me31B::GFP. The higher resolution images reveal that both AGO::GFP fusion 
proteins are distributed in many small puncta that are fairly evenly spread 
throughout the cytoplasm (examples of individual puncta are indicated by 
arrows). By contrast, GFP alone (D') is more uniform and lacks puncta of the size 
seen for the fusion proteins. The insets in Bʼ-Dʼ are higher resolution images of 
the regions in Bʼ-Dʼ indicated by arrows. The representation of each fluorescence 
value was changed in ImageJ (NIH) from a black and white scale (look up table; 
LUT) to the Union Jack LUT which represents the lowest fluorescence as black 
and progressively higher fluorescence levels are blue, white, and then red. 
AGO1::GFP and AGO2::GFP fluorescence is concentrated in puncta (appearing 
white and red in the insets in Bʼ,Cʼ) that are not observed for GFP (inset in D).  
Panels E-G show a portion of a nurse cell of a fixed stage 9 egg chamber probed 
with antibodies to detect AGO1 (E) and Bru (F), or both (G; AGO1 in green, Bru 
in red). The AGO1 distribution is particulate, just as for the AGO1::GFP fusion 
protein, and shows no enrichment in sponge bodies, for which Bru is a marker 
(Snee and Macdonald, 2009). Scale bars are 5 µm. 
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Figure 2.4. Sites of miRNA action in the ovary.  
Panels A-C show the distribution of MCP::GFP in nurse cells of live stage 10A 
egg chambers, with higher magnification images of cytoplasmic regions in Aʼ-Cʼ. 
Scale bars are 10 µm in A-C and 5 µm in A'-C'. A-C differ with respect to which 
reporter mRNAs with MS2 binding sites are present: A, no reporter mRNAs; B, 
reporter mRNAs lacking miR-312 binding sites; and C, reporter mRNAs with miR-
312 binding sites. The cytoplasmic MCP::GFP distributions were the same at 
earlier stages of oogenesis. Note that the size of the particles is similar to those 
marked with the AGO::GFP fusion proteins in Fig. 2.3, but the number of particles 
seen in each field is lower. The insets in Aʼ-Cʼ are a higher resolution image of 
the regions in Aʼ-Cʼ indicated by arrows, with Union Jack LUTs as described in 
the legend to Fig. 2.3. MS2::GFP in the presence of the osk reporter mRNAs, 
with or without miR-312 binding sites, is concentrated in puncta (appearing white 
and red in the insets in Bʼ,Cʼ) that are not observed with MS2::GFP alone (inset in 
Aʼ). Panels D and E show the distribution of MCP::GFP (green in D and E) 
tethered to the osk-312 reporter transcripts, and either sponge bodies (revealed 
by anti-Bru; red in D) or AGO1 puncta (red in E). The sponge bodies and AGO1 
puncta (arrows in D and E) do not colocalize with the tethered reporter transcripts 
(arrowheads in D and E). Scale bars are 5 µm in D and E. 
 
 57 
 
 
 
 58 
REFERENCES 
Aravin, A. A., Lagos-Quintana, M., Yalcin, A., Zavolan, M., Marks, D., Snyder, B., 
Gaasterland, T., Meyer, J. and Tuschl, T. (2003). The small RNA profile 
during Drosophila melanogaster development. Dev Cell 5: 337-350. 
 
Bartel, D. P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and 
function. Cell 116: 281-297. 
 
Bertrand, E., Chartrand, P., Schaefer, M., Shenoy, S. M., Singer, R. H. and Long, 
R. M. (1998). Localization of ASH1 mRNA particles in living yeast. Mol 
Cell 2: 437-445. 
 
Braat, A. K., Yan, N., Arn, E., Harrison, D. and Macdonald, P. M. (2004). 
Localization-dependent oskar protein accumulation; control after the 
initiation of translation. Dev Cell 7: 125-131. 
 
Brand, A. H. and Perrimon, N. (1993). Targeted gene expression as a means of 
altering cell fates and generating dominant phenotypes. Development 118: 
401-415. 
 
Brengues, M., Teixeira, D. and Parker, R. (2005). Movement of eukaryotic 
mRNAs between polysomes and cytoplasmic processing bodies. Science 
310: 486-489. 
 
Brennecke, J., Aravin, A. A., Stark, A., Dus, M., Kellis, M., Sachidanandam, R. 
and Hannon, G. J. (2007). Discrete small RNA-generating loci as master 
regulators of transposon activity in Drosophila. Cell 128: 1089-1103. 
 
Burgler, C. and Macdonald, P. M. (2005) Prediction and verification of microRNA 
 targets by MovingTargets, a highly adaptable prediction method. BMC 
 Genomics 6: 88. 
 
Buszczak, M., Paterno, S., Lighthouse, D., Bachman, J., Planck, J., Owen, S., 
 Skora, A. D., Nystul, T. G., Ohlstein, B., Allen, A., Wilhelm, J. E., Murphy, 
 T. C., Levis, R. W., Matunis, E., Srivali, N., Hoskins, R. A., and Spradling
 ,A. C. (2007). The carnegie protein trap library: a versatile tool for 
 Drosophila developmental studies. Genetics 175: 1505-1531. 
 
 59 
Chen, Y., Pane, A., and Schupbach, T. (2007). Cutoff and aubergine mutations  
  result in retrotransposon upregulation and checkpoint activation in 
 Drosophila. Curr Biol 17: 637-642. 
 
Chendrimada, T. P., Finn, K. J., Ji, X., Baillat, D., Gregory, R. I., Liebhaber, S. A., 
Pasquinelli, A. E. and Shiekhattar, R. (2007). MicroRNA silencing through 
RISC recruitment of eIF6. Nature 447: 823-828. 
 
Chu, C.-y. and Rana, T. M. (2006). Translation repression in human cells by 
microRNA-induced gene silencing requires RCK/p54. Plos Biol 4: e210. 
 
Cook, H. A., Koppetsch, B. S., Wu, J. and Theurkauf, W. E. (2004). The 
Drosophila SDE3 homolog armitage is required for oskar mRNA silencing 
and embryonic axis specification. Cell 116: 817-829. 
 
Delanoue, R., Herpers, B., Soetaert, J., Davis, I., and Rabouille, C. (2007).  
 Drosophila  Squid/hnRNP helps Dynein switch from a gurken mRNA 
 transport motor to an ultrastructural static anchor in sponge bodies. Dev 
 Cell 13: 523-538. 
 
Doench, J. G. (2003). siRNAs can function as miRNAs. Genes & Development 
17: 438-442. 
 
Doench, J. G. and Sharp, P. A. (2004). Specificity of microRNA target selection in 
 translational repression. Genes Dev 18: 504-511. 
 
Eulalio, A., Behm-Ansmant, I., Schweizer, D., and Izaurralde, E. (2007). P-body 
 formation is a consequence, not the cause, of RNA-mediated gene 
 silencing. Mol Cell Biol 27:  3970-3981. 
 
Findley, S. D. (2003). Maelstrom, a Drosophila spindle-class gene, encodes a 
protein that colocalizes with Vasa and RDE1/AGO1 homolog, Aubergine, 
in nuage. Development 130: 859-871. 
 
Forrest, K. M. and Gavis, E. R. (2003). Live imaging of endogenous RNA reveals 
a diffusion and entrapment mechanism for nanos mRNA localization in 
Drosophila. Curr Biol 13: 1159-1168. 
 
Förstemann, K., Tomari, Y., Du, T., Vagin, V. V., Denli, A. M., Bratu, D. P., 
Klattenhoff, C., Theurkauf, W. E. and Zamore, P. D. (2005). Normal 
microRNA Maturation and Germ-Line Stem Cell Maintenance Requires 
 60 
Loquacious, a Double-Stranded RNA-Binding Domain Protein. Plos Biol 3: 
e236. 
 
Gunawardane, L. S., Saito, K., Nishida, K. M., Miyoshi, K., Kawamura, Y., 
 Nagami, T., Siomi, H., and Siomi, M. C. (2007). A slicer-mediated  
 mechanism for repeat-associated siRNA 5' end formation in Drosophila. 
 Science 315: 1587-1590. 
 
Harris, A. N., and Macdonald, P. M. (2001). Aubergine encodes a Drosophila 
 polar granule component required for pole cell formation and related to 
 eIF2C. Development 128: 2823-2832. 
 
Haseloff, J. (1999). GFP variants for multispectral imaging of living cells. Methods 
  Cell Biol 58: 139-151. 
 
Humphreys, D. T., Westman, B. J., Martin, D.I., and Preiss, T. (2005).  
 MicroRNAs  control translation initiation by inhibiting eukaryotic initiation 
 factor 4E/cap and poly(A)  tail function. Proc Natl Acad Sci U S A 102: 
 16961-16966. 
 
Kennerdell, J. R. (2002). RNAi is activated during Drosophila oocyte maturation 
in a manner dependent on aubergine and spindle-E. Genes & 
Development 16: 1884-1889. 
 
Kim-ha, J., Smith, J. L., and Macdonald, P. M. (1991). oskar mRNA is localized to 
  the posterior of the Drosophila oocyte. Cell 66: 23-35.  
 
Kiriakidou, M., Tan, G. S., Lamprinaki, S., De Planell-Saguer, M., Nelson, P. T. 
and Mourelatos, Z. (2007). An mRNA m7G cap binding-like motif within 
human Ago2 represses translation. Cell 129: 1141-1151. 
 
Leung, A. K., Calabrese, J. M., and Sharp, P.A. (2006). Quantitative analysis of 
 Argonaute protein reveals microRNA-dependent localization to stress 
 granules. Proc Natl  Acad Sci U S A 103: 18125-18130. 
 
Lim, A. K. and Kai, T. (2007). Unique germ-line organelle, nuage, functions to 
 repress selfish genetic elements in Drosophila melanogaster. Proc  Natl 
 Acad Sci U S A 104: 6714-6719. 
 
 61 
Lin, M. D., Fan, S. J., Hsu, W. S., and Chou, T. B. (2006). Drosophila decapping 
 protein 1, dDcp1, is a component of the oskar mRNP complex and 
 directs its posterior  localization in the oocyte. Dev Cell 10: 601-613. 
 
Lipshitz H.D. and Smibert C.A. (2000). Mechanisms of RNA localization and 
 translational  regulation. Curr Opin Genet Dev 10: 476-488. 
 
Liu, J., Valencia-Sanchez, M. A., Hannon, G. J. and Parker, R. (2005). 
MicroRNA-dependent localization of targeted mRNAs to mammalian P-
bodies. Nat Cell Biol 7: 719-723. 
 
Maroney, P. A., Yu, Y., Fisher, J. and Nilsen, T. W. (2006). Evidence that 
microRNAs are associated with translating messenger RNAs in human 
cells. Nat Struct Mol Biol 13: 1102-1107. 
 
Martin., S. G. and St Johnston, D. (2003). A role for Drosophila LKB1 in anterior-
 posterior axis formation and epithelial polarity. Nature 421: 379-384. 
 
Meyer, W. J., Schreiber, S., Guo, Y., Volkmann, T., Welte, M. A., and Muller, H. 
 A. J. (2006). Overlapping functions of argonaute proteins in patterning 
 and morphogenesis of Drosophila embryos. PLoS Genet 2: e134. 
 
Morin, X., Daneman, R., Zavortink, M., and Chia, W. (2001). A protein trap  
 strategy to  detect GFP-tagged proteins expressed from their  
 endogenous loci in  Drosophila. Proc Natl Acad Sci U S A 98: 15050-
 15055. 
 
Nakamura, A., Amikura, R., Hanyu, K., and Kobayashi, S. (2001). Me31B  
 silences translation of oocyte-localizing RNAs through the formation of 
 cytoplasmic  RNP complex during Drosophila oogenesis. Development 
 128: 3233-3242. 
 
Nakamura, A., Sato, K. and Hanyu-Nakamura, K. (2004). Drosophila cup is an 
eIF4E binding protein that associates with Bruno and regulates oskar 
mRNA translation in oogenesis. Dev Cell 6: 69-78. 
 
Nelson, P. T. (2004). miRNP:mRNA association in polyribosomes in a human 
neuronal cell line. RNA 10: 387-394. 
 
Neumuller, R. A., Betschinger, J., Fischer, A., Bushati, N., Poernbacher, I., 
Mechtler, K., Cohen, S. M., and Knoblich, J. A. (2008). Mei-P26 regulates 
 62 
microRNAs and cell growth in the Drosophila ovarian stem cell lineage. 
Nature 454: 241-245. 
 
Nottrott, S., Simard, M. J. and Richter, J. D. (2006). Human let-7a miRNA blocks 
protein production on actively translating polyribosomes. Nat Struct Mol 
Biol 13: 1108-1114. 
 
Okamura, K. (2004). Distinct roles for Argonaute proteins in small RNA-directed 
RNA cleavage pathways. Genes & Development 18: 1655-1666. 
 
Pane, A., Wehr, K., and Schupbach, T. (2007). zucchini and squash encode two 
 putative nucleases required for rasiRNA production in the Drosophila 
 germline. Dev Cell 12: 851-862. 
 
Petersen, C. P., Bordeleau, M.-E., Pelletier, J. and Sharp, P. A. (2006). Short 
RNAs repress translation after initiation in mammalian cells. Mol Cell 21: 
533-542. 
 
Pillai, R. S., Bhattacharyya, S. N., Artus, C. G., Zoller, T., Cougot, N., Basyuk, E., 
Bertrand, E. and Filipowicz, W. (2005). Inhibition of translational initiation 
by Let-7 MicroRNA in human cells. Science 309: 1573-1576. 
 
Rajavel, K. S. and Neufeld, E.F. (2001). Nonsense-mediated decay of human 
 HEXA  mRNA. Mol Cell Biol 21: 5512-5519. 
 
Rorth, P. (1998). Gal4 in the Drosophila female germline. Mech Dev 78: 113-118. 
 
Saito, K., Nishida, K. M., Mori, T., Kawamura, Y., Miyoshi, K., Nagami, T., Siomi, 
 H., and Siomi, M. C. (2006). Specific association of Piwi with rasiRNAs 
 derived from retrotransposon and heterochromatic regions in the 
 Drosophila genome. Genes Dev 20: 2214-2222. 
 
Saxena, S., Jonsson, Z. O., and Dutta, A. (2003). Small RNAs with imperfect 
 match to endogenous mRNA repress translation. Implications for off-target 
 activity of small inhibitory RNA in mammalian cells. J Biol Chem 278: 
 44312-44319. 
 
Sen, G. L. and Blau, H. M. (2005). Argonaute 2/RISC resides in sites of 
mammalian mRNA decay known as cytoplasmic bodies. Nat Cell Biol 7: 
633-636. 
 
 63 
Snee, M., Benz, D., Jen, J., and Macdonald, P.M. (2008). Two distinct domains 
 of Bruno bind specifically to the oskar mRNA. RNA Biol 5: 49-57. 
 
Snee, M. J. and Macdonald, P. M. (2004). Live imaging of nuage and polar 
 granules: evidence against a precursor-product relationship and a novel 
role for  Oskar in stabilization of polar granule components. J Cell Sci 117: 
 2109-2120. 
 
Snee, M. J. and Macdonald, P. M. (2009). Dynamic organizaton and plasticity of 
 sponge bodies. Developmental Dynamics 238: 918-930. 
 
Styhler, S., Nakamura, A., and Lasko, P. (2002). VASA localization requires the 
 SPRY-domain and SOCS-box containing protein, GUSTAVUS. Dev Cell 3: 
 865-876. 
 
Teixeira, D., Sheth, U., Valencia-Sanchez, M. A., Brengues, M. and Parker, R. 
(2005). Processing bodies require RNA for assembly and contain 
nontranslating mRNAs. RNA 11: 371-382. 
 
Vagin, V. V., Sigova, A., Li, C., Seitz, H., Gvozdev, V., and Zamore, P. D. (2006). 
 A distinct small RNA pathway silences selfish genetic elements in the 
 germline. Science 313: 320-324. 
 
Wilhelm, J. E., Mansfield, J., Hom-Booher, N., Wang, S., Turck, C. W., Hazelrigg, 
T. and Vale, R. D. (2000). Isolation of a ribonucleoprotein complex 
involved in mRNA localization in Drosophila oocytes. J Cell Biol 148: 427-
440. 
 
Wilhelm, J. E., Hilton, M., Amos, Q., and Henzel, W. J. (2003). Cup is an eIF4E 
 binding protein required for both the translational repression of oskar and 
 the recruitment of Barentsz. J Cell Biol 163: 1197-1204. 
 
Wilsch-Bräuninger, M., Schwarz, H. and Nüsslein-Volhard, C. (1997). A sponge-
like structure involved in the association and transport of maternal 
products during Drosophila oogenesis. J Cell Biol 139: 817-829. 
 
Wilson, J. E., Connell, J. E. and Macdonald, P. M. (1996). aubergine enhances 
oskar translation in the Drosophila ovary. Development 122: 1631-1639. 
 
 64 
Yang, L., Chen, D., Duan, R., Xia, L., Wang, J., Qurashi, A., Jin, P. and Chen, D. 
(2007). Argonaute 1 regulates the fate of germline stem cells in 
Drosophila. Development 134: 4265-4272. 
 
Yang, Z., Jakymiw, A., Wood, M. R., Eystathioy, T., Rubin, R. L., Fritzler, M. J. 
and Chan, E. K. L. (2004). GW182 is critical for the stability of GW bodies 
expressed during the cell cycle and cell proliferation. J Cell Sci 117: 5567-
5578. 
 
 66 
Chapter 3: oskar mRNA both modulates and responds to Bruno 
repressive activity 
ABSTRACT 
 The oskar mRNA has two distinct functions. It encodes Oskar protein, 
which directs assembly of posterior pole plasm in the oocyte, an essential step in 
embryonic body patterning and germ cell formation. Mutants lacking Oskar 
protein complete oogenesis, but the resulting embryos lack abdominal segments 
and germ cells. The second function of oskar RNA is independent of its ability to 
encode a protein. Mutants lacking oskar mRNA arrest oogenesis, and this defect 
can be rescued by expression of just the oskar mRNA 3' UTR. Possible models 
for oskar RNA function include serving as a scaffold for assembly of 
ribonucleoprotein particles required for progression through oogenesis, or 
sequestration of regulatory factors to prevent their inappropriate action on other 
mRNAs. Here we show that the RNA function of oskar mRNA requires BREs, 
binding sites for the translational repressor Bruno. Depletion of available Bruno 
partially rescues the oskar RNA null phenotype, consistent with the model in 
which oskar mRNA sequesters Bruno and thus limits its binding to other 
substrates. Thus, Bruno and oskar define a regulatory loop in which Bruno limits 
the activity of oskar mRNA via translational repression while oskar mRNA limits 
Bruno activity by sequestration. 
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INTRODUCTION 
 Interactions between mRNAs and proteins are crucial for control of gene 
expression. Regulatory proteins bind to control elements in mRNAs, thereby 
influencing processing, modification, localization, translation and stability of the 
mRNAs. Such post-transcriptional control is now known to be widespread, 
although the diversity and significance of this form of regulation was initially 
revealed in large part from studies of early animal development. In many animals, 
key events in early embryogenesis are programmed by maternal mRNAs 
provided in the egg. Expression of these mRNAs must often occur at specific 
times and places, and post-transcriptional control restricts the patterns of 
expression [reviewed in (Besse and Ephrussi, 2008; Bastock and St Johnston, 
2008; Dean et al., 2002)].  
 Control of maternal mRNA expression is especially notable in Drosophila 
oogenesis and embryogenesis. The proteins that specify axial patterning are 
deployed only at specific sites in the egg and embryo, and are translated from 
mRNAs that are prelocalized during oogenesis to discrete positions within the 
oocyte (Riechmann and Ephrussi, 2001; St Johnston et al., 1989; Huynh and St 
Johnston, 2004; Lehmann and Nusslein-Volhard, 1986). One such mRNA is 
oskar (osk). From the earliest stages of oogenesis the osk mRNA is synthesized 
in the nurse cells and transported to the oocyte, where it becomes highly 
concentrated (Kim-Ha et al., 1991; Ephrussi et al., 1991). Later in oogenesis, 
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beginning at stage 9, osk mRNA is localized to the posterior pole of the oocyte 
and Osk protein first appears (Kim-Ha et al., 1991; Eprhussi et al., 1991; Kim-Ha 
et al., 1995). Prior to this localization osk mRNA is translationally repressed by 
Bruno (Bru), which binds to regulatory elements, BREs, in the osk mRNA 3' UTR 
(Kim-Ha et al., 1995; Webster et al., 1997). Additional regulatory elements and 
factors contribute to osk mRNA localization and translational regulation. The only 
other narrowly defined osk mRNA regulatory element is the IBE, which is present 
in multiple copies throughout the 3' UTR and is required for activation of 
translation (Munro et al, 2006). The factor that mediates the action of the IBEs 
has not been identified. In addition to Bru, RNA binding proteins involved in 
localization and translation include Stau, Hrp48, PTB and Orb (St Johnston et al., 
1991; Besse et al., 2009; Castagnetti and Ephrussi, 2003; Micklem et al, 2000; 
Huynh et al., 2004). Not surprisingly, given the array of regulatory factors, osk 
mRNA has been detected in large RNP complexes (Chekulaeva et al., 2006; 
Besse et al., 2009)  
 All known point mutations of the osk gene result in the classical 
phenotype, a loss of abdominal segments in the embryo (Eldon and Pirrotta et 
al., 1991; Markussen et al., 1995; Jankovics et al., 2001; Martin et al., 2003; 
Yohn et al., 2003; Luschnig et al., 2004). This was thought to be the null 
phenotype, as several of the mutants are nonsense alleles and make no 
detectable Osk protein (Kim-Ha et al., 1991). More recently, however, new osk 
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alleles were isolated with a novel phenotype: progression through oogenesis is 
blocked at stage 7/8, well before Osk protein first appears. The new mutants 
have drastically reduced levels of osk mRNA, and progression through oogenesis 
can be rescued by expression of just the 3' UTR of the osk mRNA (Jenny et al., 
2006). Thus, the osk mRNA has a developmental role independent of its ability to 
encode a protein. Models have been proposed for this role. The principal model 
posits that the osk mRNA provides a scaffold for transport into the oocyte of 
proteins or RNAs essential for its development. For example, Stau protein 
requires osk mRNA for its concentration in the oocyte, although Stau itself is not 
a candidate for a factor whose deposition in the oocyte is critical (stau mutants do 
not block progression through oogenesis). An alternative model is that the osk 3' 
UTR binds and sequesters a negative regulator that would otherwise inhibit 
progression through oogenesis (Jenny et al., 2006). 
 Here we test the possibility that the essential role of the osk 3' UTR is to 
sequester Bru, so as to regulate the pool of free Bru and thereby prevent 'off 
target' effects. Our results very strongly support this model, and reveal a novel 
regulatory loop, in which Bru negatively regulates osk mRNA while osk mRNA in 
turn negatively regulates Bru. 
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RESULTS  
osk transgenes with wild type or mutated BREs were tested for rescue of 
the osk RNA null phenotype. osk RNA null females fail to lay any eggs owing to 
the arrest of oogenesis, and restoration of egg laying provides a quantitative 
assay for the degree of rescue. Introduction of the wild type osk transgene into 
the osk RNA null background provides strong rescue (Fig. 3.1A).  In contrast, an 
osk transgene with all of the previously identified BREs mutated (now called osk 
ABC I-; see below) rescues only poorly: egg laying is severely reduced relative to 
the osk+ transgene (Fig. 3.1A), and ovaries contain many egg chambers that 
have arrested development. Transgenes with only a subset of these BREs 
mutated, either those in the AB region (osk AB I-) or those in the C region (osk C 
I-) produce intermediate phenotypes: egg laying is rescued to a greater degree 
than with the osk ABC I- transgene, and fewer egg chambers are arrested in 
development. The RNA levels of all these transgenes are very similar (Fig. 3.1B), 
and so the differences in their activities must be due to mutation of the BREs. 
Thus, the osk null phenotype can be attributed, at least in part, to the loss of 
BREs that occurs when osk mRNA is absent. 
The previously established role of BREs in translational control is 
mediated by Bru (Kim-Ha et al., 1995; Webster et al., 1997; Lie and Macdonald, 
1999). Therefore, Bru is a strong candidate to act in the novel function of osk 
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BREs in egg chamber development. Alternatively, a different and as yet 
unidentified BRE-binding factor could be responsible. In an initial series of tests 
to distinguish between these options, we monitored the effect of altering the level 
of Bru protein on the osk null phenotype. Two different types of experiments were 
performed: reducing the level of Bru in combination with the incomplete rescue 
by the osk ABC I- mRNA; and reducing Bru level in combination with addition of 
exogenous BRE-containing RNAs (to bind and thus sequester Bru).  
To reduce the level of Bru one copy of arrest (aret), the gene that encodes 
Bru, was deleted. Females heterozygous for the aret- deficiency Df(2L)aret have 
~75% of the normal level of Bru (Fig. 3.1D). Females that are Df(2L)aret/+; 
oskA87/Df(3R)osk do not lay any eggs, and have ovaries indistinguishable from 
those of oskA87/Df(3R)osk females (Fig. 3.3, Fig. 3.2), revealing that this modest 
reduction in Bru level alone does not affect the osk RNA null phenotype. 
However, suppression of the osk RNA null egg laying phenotype by the osk ABC 
I- mRNA is significantly enhanced when one copy of aret is deleted (Fig. 3.1C), 
arguing that the role of the osk BREs in egg chamber development does involve 
Bru. 
In the second type of experiment we again reduced the overall level of Bru 
using Df(2L)aret, and in addition reduced the level of free Bru by providing other 
RNAs bearing BREs. Two of these RNAs - GFP-grk and osk-16xBRE-K10 - are 
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derived from Drosophila mRNAs normally present in the ovary. Both were 
expressed using the UAS/GAL4 system. GFP-grk has the coding region for GFP 
with the 3' UTR of the gurken (grk) mRNA. The grk 3' UTR is bound in vitro by 
Bru, and appears to be under Bru control in vivo (Yan and Macdonald, 2004; 
Filardo et al., 2003). The osk-16xBRE-K10 mRNA has the osk coding region and 
a portion of the fsK10 3' UTR to which 16 multimerized BREs from the osk C 
region have been added. Neither GFP-grk nor osk-16xBRE-K10 mRNA alone 
rescued the egg laying defect of the osk null mutant (Fig. 3.2) To detect weaker 
forms of rescue, ovaries of these flies were examined to determine the stage at 
which oogenesis arrests. The osk null egg chambers arrest oogenesis at stage 7. 
A similar stage of arrest is observed in osk null females expressing either GFP-
grk or osk-16xBRE-K10, or heterozygous for Df(2L)aret. However, when 
expression of either RNA is combined with reduction in Bru levels, egg chambers 
at later stages of oogenesis are observed (Fig. 3.2).  
These results support the model that excess free Bru underlies, at least in 
part, the osk RNA null phenotype. Whether the RNA function of osk is mediated 
by BREs alone, or by a combination of BREs and other features of the osk 3' 
UTR, is uncertain. The GFP-grk and osk-16xBRE-K10 mRNAs are much less 
effective than osk mRNA in rescuing the osk RNA null phenotype. This difference 
could reflect number of BREs and/or levels of expression of the different 
transcripts, the involvement of osk 3' UTR elements other than BREs, or a 
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combination of these options. The behavior of the osk transgene with all the 
known BREs mutated – incomplete rescue of the osk null phenotype – suggests 
that the BREs are important but not essential for osk RNA function. However, 
such an argument relies on the assumption that all osk mRNA BREs have been 
identified. 
To determine if there are Bru binding sites distinct from the original BREs, 
in vitro selections were performed for RNA aptamers that bind Bru (B. Reveal et 
al., in preparation). Analysis of the aptamers recovered from the selections 
revealed a surprising complexity in Bru binding specificity; the full details of the 
results and analysis will be described elsewhere. For the present work, three 
features of the aptamer sequences are relevant. First, as would be expected, a 
sequence present in multiple aptamers encompasses the original BRE, now 
called a type I BRE. Second, the sequence that appears most frequently in the 
aptamers selected with full length Bru is UUGUCY, where Y is a pyrimidine. 
UUGUCY appears three times in the osk mRNA, with a notable distribution: all 
sites are embedded among the type I BREs in the AB and C regions of the 3' 
UTR (Fig. 3.4A). This sequence is called a type II BRE. Third, an additional 
sequence present in aptamers selected with the Bru RRM 3+ protein (Snee et al., 
2008) is CAAAGUNUUCYR (R is a purine). The only close match to this 
sequence in the osk mRNA, UAAAGUCUUCUA, differs by a single nucleotide 
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and is adjacent to the BREs in the C region (Fig. 3.4A). We refer to this as a type 
III BRE. 
UV crosslinking assays with ovarian extracts were used to confirm that 
each type of BRE contributes to Bru binding (Fig. 3.4B). Mutation of type I BREs 
causes the most severe reduction of Bru binding to either AB and C region 
RNAs. Mutation of type II BREs also reduces binding to the AB and C regions, 
but to a lesser extent. Mutation of the single type III BRE, in the C region, results 
in a small but reproducible reduction in binding. In sum, the selections reveal 
several novel Bru binding sites in the osk mRNA, and all examples of the new 
sites are positioned in the immediate vicinity of the original BREs. 
The osk transgene bearing mutations in the previously identified BREs 
(osk ABC I-) was further modified to inactivate the additional sites, making osk 
ABC all-. When placed in the oskA87/Df(3R)osk background, the osk ABC all- 
transgene provides no rescue of the oogenesis arrest (Fig. 3.1A, 3.4D), even 
though the mutant mRNA is present at a level similar to that of the other 
transgenes tested (Fig. 3.1B). We conclude that the BREs are essential for osk 
RNA function. 
 Although our evidence clearly demonstrates that BREs are necessary for 
osk RNA function, we do not know if they are sufficient. One approach to 
addressing this question relies on synthetic BREs, such as the aptamers we 
obtained through in vitro selection of Bru binding sites. The aptamers are 
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extremely unlikely to include, by chance, any other feature of the osk 3' UTR 
important for osk RNA function. We tested two transgenes bearing multimerized 
copies of two different aptamers that bind Bru with high affinity, expressing them 
under UAS/GAL4 control in oskA87/Df(3R)osk ovaries. Both behave much like 
the UAS-GFP-grk and UAS-osk-16xBRE transgenes: in combination with 
heterozygosity for Df(2L)aret they weakly rescue the osk RNA null phenotype, 
but do not do so on their own (Fig. 3.5).  
DISCUSSION  
Our results demonstrate that the BREs are essential for egg chamber 
progression through oogenesis. Mutations of all osk BREs leads to an arrest of 
oogenesis equivalent to absence of osk mRNA (Fig. 3.4D).  Currently, It is 
unclear whether the BREs are sufficient for progression of oogenesis. Expression 
of exogenous BREs in egg chambers will partially rescue the osk RNA null arrest 
of oogenesis, but only does so if the concentration of Bru is reduced (Fig. 3.2 and 
4). Although this result appears to suggest that BREs are not sufficient for osk 
RNA function, the osk mRNA is highly expressed, and the AB and C regions of 
the osk mRNA have very high densities of Bru binding sites (Fig. 3.4A). 
Consequently, even the multimerized aptamers may be significantly less effective 
than the osk mRNA at binding Bru, and thus unable to serve as a substitute. 
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It has been proposed that the function of osk RNA is to serve as a scaffold 
for assembly of a RNP complex and delivery to the oocyte. Continued 
development of the oocyte would require the RNP complex (Jenny et al., 2006). 
Because the BREs are essential for osk RNA function, and the only known BRE 
binding protein is Bru, the simplest form of this model is that it is an osk RNA/Bru 
complex that supports oocyte development. By this model, reducing the level of 
either osk mRNA or Bru protein should interfere with complex formation and thus 
enhance an intermediate osk RNA null phenotype. Reducing the level of osk 
mRNA has the expected consequence, but reducing the level of Bru suppresses 
the phenotype. Therefore, to accommodate the scaffold model we would have to 
assume that Bru plays a negative role, interfering with scaffold assembly. This 
would presumably occur through competition with one or more scaffolding factors 
for binding to the BREs in the osk mRNA. Although plausible, this would require 
either a single factor that shares with Bru the ability to bind to several different 
types of BREs, or multiple factors that collectively bind to the different BREs.  
An alternate model for the function of osk RNA is that it sequesters a 
regulatory factor, and thereby prevents that factor from binding inappropriately to 
other RNAs (Jenny et al., 2006). This model fits well with our results. Specifically, 
osk mRNA would bind Bru and limit the pool of free Bru. Because the osk mRNA 
is very abundant and contains many Bru binding sites (Fig. 3.4A), its capacity for 
binding Bru is substantial. In the absence of osk mRNA, the now large pool of 
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free Bru could bind promiscuously, with increased occupancy of lower affinity 
sites in other mRNAs. Lowering the level of Bru would counteract this effect: a 
reduction in the pool of free Bru would curtail the promiscuous binding, and thus 
weaken the osk RNA null phenotype. A strong prediction of this model is that the 
spectrum of mRNAs associated with Bru should be expanded when osk mRNA is 
absent. To test this prediction, we are currently performing microarray analysis of 
cDNA prepared from RNA coimmunoprecipitated from ovary extracts (RIP-CHIP 
analysis). These results may provide strong positive evidence supporting the 
model that the role of osk RNA in early oogenesis is to sequester Bru and thus 
limit its ability to bind and regulate other mRNAs. 
 The osk BREs have two essential functions during development, both of 
which rely on the BREs ability to bind Bru. One function is the translational 
repression of the osk mRNA. Bru binds to the osk BREs, preventing ectopic 
expression of Osk protein, and consequently, posteriorization of the embryo 
(Kim-Ha et al., 1995; Webster et al., 1997). The other function is to sequester 
Bru, decreasing the concentration of free Bru and potentially preventing Bru from 
misregulating other transcripts. Indeed, ovarian defects caused by the over-
expression of Bru have been attributed to Bru binding, and misregulating 
mRNAs, and these defects are suppressed by over-expression of the osk 3ʼ UTR 
(Filardo et al., 2003) . The osk BRE-Bru interaction provides a novel regulatory 
loop, where Bru binding to BREs prevents ectopic expression of Osk protein, and 
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the osk BREs binding to Bru titrates the concentration of free Bru, preventing 
misregulation of mRNAs.  oskar titration of Bru is reminiscent of transcriptional 
repression of the ftz gene by Tramtrack (Ttk) during embryogenesis. The 
transcriptional repressor Tramtrack (Ttk) is maternally loaded into the embryo, 
where it represses transcription of the ftz gene. During embryogenesis, the 
embryo undergoes a number of nuclear divisions in the absence of cell division, 
increasing the concentration of nuclei and, consequently, Ttk binding sites. Ttk is 
subsequently sequestered by the high concentration of its binding sites, 
prohibiting it from repressing transcription of ftz (Pritchard and Schubiger, 1996).   
MATERIALS AND METHODS 
Flies 
 oskA87 was from Anne Ephrussi (Jenny et al., 2006). Df(3R)osk has a 23 
kb deletion that removes four genes: osk, CG11963, CG11964 and CG11966 
(submitted). Df(2L)aret was constructed by FRT-mediated recombination (Parks, 
Cook et al. 2004) using Exelixis transposon insertions P{XP}aretd07449 and 
PBac{WH}bru-2f00171. The resulting deletion of 83,892 nt removes CG31862, 
CG17010 and parts of aret and bru-2.  
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Transgenes 
 UAS-GFP-grk (p8607) consists of UAS-GFP (submitted) with a BRE-
containing segment of the grk 3' UTR (nt 1459-1693 of GenBank Accession 
NM_057220.3) inserted as a BglII-BamHI fragment in the pUASp vector BamHI 
site in the 3' UTR. UAS-osk-16xBRE (p8444) consists of UAS-osk (Snee et al., 
2007) with the multimerized 16xBRE (Webster et al., 1997)  inserted as a BamHI-
BglII fragment in the pUASp vector BamHI site in the 3' UTR. The osk ABC I- 
transgene (Kim-Ha et al., 1995) previously called osk ABC-) has the mutations 
shown underlined in the sequences below, with the osk AB I- and osk C I- 
transgenes having only the AB or C region mutations. The AB and C sequences 
shown correspond to nt 2669-2798 and nt 3400-3555 of the osk genomic 
sequence (GenBank Accession M63492), respectively.  
AB: 
GAATTCGCTTAGTTTTAATTAGTTTTTAATTGAGATTGTTCTCTGTCTTTGTTA
TTTTAGATTTTCGTGCACTTGTCCTAGTCCATTATTTTAGATTATTTTGGGTTT
TGGTTTCTTAGTTAGATTTAAA 
C: 
TTCTGGCGTAATTTACAGCTCTACTTTAAAGTCTTCTAGATAGCTATCTACTA
TTTATAAACTTATTTATTGTCTTGAATTTGAGTTAACTTGAGTTATTGATGGTG
ATCACGTTTTTTTTGTCCTATAACAAGCTGCAATGTAAAATCCAAAAAA 
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The osk ABC all- transgene has the mutations shown underlined in the 
sequences below. 
AB: 
GAATTCGCTTAGTTTTAATTAGTTTTTAATTGAGATTGTTCTCTGTCTTTGTTA
TTTTAGATTTTCGTGCACTCGCTTTAGTCCATTATTTTAGATTATTTTGGGTTT
TGGTTTCTTAGTTAGATTTAAA 
C: 
TTCTGGCGTAATTTACAGCTCTACTTATACTATCGTATGATAGCTATCTACTA
TTTATAAACTTATTTATCGCTTTGAATTTGAGTTAACTTGAGTTATTGATGGTG
ATCACGTTTTTTTCGCTTTATAACAAGCTGCAATGTAAAATCCAAAAAA 
Egg laying assay 
 Newly emerged flies [oskA87/Df(3R)osk with an osk transgene] were 
placed in yeasted vials for 2-4 days, then transferred into small population cages 
with apple juice plates and yeast paste. Eggs were harvested over a 50-60 hour 
period with plates changed every 8-12 hours. In all cases the rate of egg laying 
for an osk+ transgene in the oskA87/Df(3R)osk background was set as 100%. 
Scoring for egg laying over several days averages out the substantial fluctuations 
in egg laying rates that occur over shorter intervals.  
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Western blots 
 Ovaries were collected on ice and homogenized in SDS-PAGE loading 
buffer with protease inhibitors (5mM benzamidine and 10mM PMSF).  Samples 
were boiled for 5 minutes and loaded on a SDS-PAGE gel.  Western blots were 
performed using the LI-COR detection system according to the manufacturers 
instructions and imaged using a Odyssey Infrared Imaging System (LI-COR 
Biosciences). Bru protein levels were normalized relative to b-tubulin.  All 
experiments were performed at least 3 times.  Anti-Bru antibodies used in the 
analysis were a gift from Mary Lilly (1:3000 dilution).  β-tubulin antibody used  in 
the analysis was the monoclonal antibody E7 from the Developmental Studies 
Hybridoma Bank (1:1000 dilution). 
Microscopy 
 Ovaries of 3-4 day old females, maintained with males in yeasted vials, 
were dissected and fixed (Harris and Macdonald 2001). Samples were stained 
with Alexa Fluor 488 phalloidin (Molecular Probes--Invitrogen) , TO-PRO-3 iodide 
(Molecular Probes--Invitrogen)  and mounted in Vectashield (Vector 
Laboratories). Imaging was performed with a Leica TCS-SP confocal 
microscope.  
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Figures 
Figure 3.1. BREs are required for the RNA function of osk. 
A. Egg laying assay. Rates of egg laying (see Methods) for females lacking 
endogenous osk mRNA [oskA87/Df(3R)osk] but carrying an osk transgene, as 
indicated. The rate obtained with the osk+ transgene was set at 100%.  
B. Transcript levels for osk transgenes. The rp49 mRNA was used as a control to 
ensure that similar amounts of ovarian RNA were used for each genotype. 
C. Egg laying assay. Rates of egg laying for females lacking endogenous osk 
mRNA [oskA87/Df(3R)osk] but carrying a osk+ or osk ABC I- transgene were 
determined, testing the consequences of reducing Bru level by heterozygosity for 
Df(2L)aret. The osk ABC I- transgenic line used is different from that in panels A 
and B, and has slightly greater rescuing activity. 
D. Analysis of Bru protein level in wild type (w1118) or Df(2L)aret/CyO ovaries. 
Protein levels were determined by quantitative western blots, with beta-tubulin 
used as a loading control. 
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Figure 3.2. Reduction in the level of Bru suppresses the osk RNA null 
phenotype. 
 
The two columns show images of oskA87/Df(3R)osk ovaries with both copies of 
the aret gene (left) or with one copy of aret removed by the Df(2L)aret deficiency. 
All flies carry the nosGAL4VP16 driver, and transgenes as indicated at left. The 
ovaries were stained with Alexa488-phallodin to label filamentous actin (green) 
and ToPro to label nuclei (red). In the case of the UAS-GFP-grk 3' UTR 
transgene, the GFP signal (green) is superimposed on the actin signal. None of 
the transgenes suppress the osk RNA null phenotype. Similarly, removing one 
copy of aret has no effect on the osk RNA null phenotype. In contrast, the 
combination of expressing a transgene with BREs and removing one copy of aret 
allows oogenesis to proceed to stage 9, a partial suppression of the osk RNA null 
phenotype. The UAS-osk transgene, which has no BREs, serves as a control for 
the UAS-osk-16xBRE transgene.  
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Figure 3.3. The osk RNA null egg laying defect is unaffected by a modest 
reduction of Bru.  
Egg laying assay. Egg laying for females lacking endogenous osk mRNA 
[oskA87/Df(3R)osk]  when Bru levels are reduced. Number of eggs laid was 
determined from females hemizygous for Bru, or females expressing exogenous 
BREs, as indicated. No eggs were laid for any of the genotypes tested. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 87 
 
Figure 3.4 BREs in the osk mRNA are essential for osk RNA function. 
A. Diagram of the osk mRNA 3' UTR. Positions of the different classes of BREs 
are indicated as shown, and the AB and C regions are marked below. The 
sequence given for the type I BRE is that from Kim-Ha et. al (1995)ref, except 
that variability at the purine positions is not noted; both possible options at each 
position are found. The type I BRE is contained within one class of Bru binding 
site defined by SELEX, which is longer and has the sequence 
UGUUUUAUAUGU.  
B. UV crosslinking assay using radiolabeled osk AB or C RNA as probe, either 
wild type (+) or with the BREs mutated as noted, and ovarian extract.   
C and D. images of oskA87/Df(3R)osk egg chambers without (C) or with the osk 
ABC all- transgene (D). 
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Figure 3.5. Expression of synthetic BREs suppresses the osk RNA null 
phenotype. 
The two columns show images of oskA87/Df(3R)osk ovaries with both copies of 
the aret gene (left) or with one copy of aret removed by the Df(2L)aret deficiency. 
All flies carry the nosGAL4VP16 driver, and transgenes as indicated at left. The 
ovaries were stained with Alexa488-phallodin to label filamentous actin (green) 
and ToPro to label nuclei (red). In the case of both UAS-GFP transgenes, the 
GFP signal (green) is superimposed on the actin signal. Neither of the 
transgenes suppresses the osk RNA null phenotype. In contrast, the combination 
of expressing a transgene with BREs and removing one copy of aret allows 
oogenesis to proceed to stage 9, a partial suppression of the osk RNA null 
phenotype. UAS-GFP-Type I BREs  contain four copies of Type I BREs inserted 
into the 3ʼ UTR (B. Reveal et al., in preparation). UAS-GFP-Type I, II BREs 
contain three copies of Type I and Type II BREs in tandem inserted into the 3ʼ 
UTR (B. Reveal et al., in preparation). 
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Chapter 4: A Genetic Screen to Identify Genes Involved in 
miRNA-mediated Regulation 
ABSTRACT 
In the past decade, small RNAs have emerged as important regulators of 
gene expression.  They regulate both mRNA transcription, and protein translation 
of a number of genes. miRNAs are a class of small RNAs that regulate mRNAs 
post-transcriptionally. With the aid of different effector proteins, miRNAs affect 
translation using multiple mechanisms. There is reason to believe that many 
factors involved in miRNA-mediated regulation have yet to be discovered. To 
identify components involved in miRNA-mediated regulation, we devised a 
genetic screen allowing us to monitor repression in the Drosophila eye. Using our 
screen, we identified seven mutants. Two mutants were mapped to different 1 Mb 
genomic regions, and are likely to encode novel proteins involved in miRNA-
mediated regulation.   
BACKGROUND 
miRNAs are a class of small regulatory RNAs, generally 21-24 nucleotides 
in length. They are found in a variety of organisms, and their presence 
throughout development is essential. miRNAs help regulate everything from stem 
cell identity to oncogenesis (Hatfield et al., 2005;  Forstemann et al., 2005; 
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Weinholds and Plasterk, 2005). Organisms unable to make mature miRNAs are 
often arrested early in development (Giraldez et al., 2006; Lee et al., 2004). 
miRNAs regulate transcripts as part of the RNP complex RISC. In its basic 
form, RISC consists of a miRNA, an Argonaute protein, and GW182 (Eulalio et 
al., 2008; Eulalio et al., 2009). The miRNA determines which transcripts are 
regulated by RISC through its base pairing interactions with the transcript (Baek 
et al., 2008; Brennecke et al., 2005). Argonaute proteins are highly conserved 
basic proteins that bind miRNAs and cause repression of targeted transcripts 
(Carmell et al., 2002). Some of Argonautes repressive capability is conferred 
through its binding to GW182. Argonaute targets GW182 to a transcript, and 
once targeted, GW182 has the ability to repress translation. (Chekulaeva et al., 
2009; Eulalio et al., 2009). 
A transcript targeted for regulation by RISC can be repressed through a 
number of post-transcriptional mechanisms. In C. elegans, the lin-4 miRNA 
regulates the lin-14 transcript. The repressed lin-14 transcripts associate with 
polysomes, even in the absence of Lin-14 protein accumulation, suggesting that 
a step after translation initiation is affected (Olsen and Ambros. 1999). miRNA-
mediated regulation also affects translation initiation. For some transcripts, 
regulation by miRNAs only occurs if the transcript has a 5ʼ cap (Pillai et al., 2005; 
Humphreys et al., 2005; Kiriakidou et al., 2007; Mathonnet et al., 2007). The MC 
domain of human Argonaute 2 binds to the 5ʼ cap and mutations that inhibit 5ʼ 
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cap binding also inhibit miRNA-mediated repression. This suggests that 
Argonaute 2 inhibits translation initiation by binding to the 5ʼ cap, possibly 
interfering with recruitment of eIF4E (Kiriakidou et al., 2007). In other instances, 
translation initiation is thought to be affected at a step after 5ʼ cap binding, during 
formation of the translationally competent 80S ribosome. The eIF6 protein is a 
regulator of 80S ribosome formation and is required for miRNA-mediated 
regulation of some transcripts. It functions by binding to the 60S ribosomal 
subunit, inhibiting 80S ribosome formation, and is thought to have a similar 
function in miRNA-mediated regulation (Ceci et al., 2003; Chendrimada et al., 
2007).    
Regulation by miRNAs can cause mRNA sequestration and 
deadenylation.  Transcripts repressed by miRNAs weakly localize to cytoplasmic 
structures called P-bodies, sites of mRNA metabolism (Pillai et al., 2005; 
Bhattacharyya et al., 2006; Eystathioy et al., 2003; Sen and Blau, 2005; Ding et 
al., 2005; Behm-Ansmant et al., 2006; Sheth and Parker, 2003; Teixeira et al., 
2005). After repressed transcripts are localized to P-bodies, they may be 
processed, degraded, or stored for future use. For example, the CAT-1 mRNA is 
repressed by miRNAs and found in P-bodies. Under conditions of stress, the 
CAT-1 mRNA can leave P-bodies and re-enter the translating pool of mRNAs 
(Bhattacharyya et al., 2006). Many transcripts regulated by miRNAs are also 
deadenylated, which may occur in P-bodies where the deadenylase complex is 
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located (Giraldez et al., 2006; Bagga et al., 2005; Behm-Ansmant et al., 2006; 
Eulalio et al., 2008).  
Past attempts to identify components involved in miRNA-mediated 
regulation have involved both biochemical and genetic approaches 
(Chendrimada et al., 2007; Gregory et al., 2004; Landthaler et al., 2008; Cook et 
al., 2004; Behm-Ansmant et al., 2006). Although there are a number of proteins 
known to function in miRNA-mediated regulation, it is likely that additional 
proteins involved in regulation remain to be identified. Recently, the endosomal 
pathway was implicated in miRNA-mediated repression. This discovery was 
made using biochemical and genetic approaches that identified proteins involved 
in gene regulation by small RNAs (Lee et al., 2009; Gibbings et al., 2009).  Here, 
we use a forward genetics approach to identify additional factors of miRNA-
mediated regulation in Drosophila melanogaster.   
RESULTS  
Screen Assay 
In human and Drosophila cells, an Argonaute protein tethered to a reporter 
RNA mimics miRNA-mediated regulation. Having an Argonaute protein tethered 
to a transcript bypasses the need for a miRNA to target that transcript for 
regulation (Pillai et al., 2004; Eulalio et al., 2008). In both cases, tethering has 
been achieved by expressing both a reporter RNA containing RNA hairpins 
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inserted into its 3ʼ UTR, and an Argonaute fused to a protein that recognizes the 
RNA hairpins. The Argonaute fusion protein can bind the reporter RNA through 
its interactions with the RNA hairpins, and repress its translation (Pillai et al., 
2004; Rehwinkel et al., 2005). Since tethering alleviates the need for a miRNA in 
targeting Argonaute to a transcript, regulation by a tethered Argonaute may also 
be independent of the miRNA processing machinery. Therefore, we adapted this 
approach for use in a genetic screen looking at miRNA-mediated regulation in the 
fly eye, expecting that a tethering assay will exclude the identification of genes 
involved in miRNA processing. 
We designed an assay that relies on the presence of two components. 
The first component is the MCP-AGO1 protein, which is Drosophila AGO1 with 
the MS2 coat protein (MCP) fused to its N-terminus. MCP binds to a 19-
nucleotide RNA stem loop (MCPSL), and this interaction has been used to tether 
proteins to mRNAs in both Drosophila melanogaster and Saccharomyces 
cerevisiae (Bertrand et al., 1998; Forrest and Gavis, 2003). In order to express 
MCP-AGO1 in the fly eye, we used the eye specific promoter GMR (Hay et al., 
1994). The combination of these different genetic elements resulted in the 
P[GMA]  transgene.  
The other component of the assay is the mini-white mRNA containing 18 
copies of the MCPSL inserted into its 3ʼ UTR (P[w+18xSL]).  Expression of mini-
white in the eye produces an easily recognized phenotype, eye pigmentation. In 
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addition, eye pigmentation is sensitive to the amount of White protein present: 
increasing concentrations of White protein causes a darker eye phenotype, 
allowing us to monitor the degree of P[w+18xSL] translational repression. 
Flies expressing P[w+18xSL] have orange eyes, while flies expressing 
both P[GMA] and P[w+18xSL] have light orange eyes (Fig. 4.1A). This reduction 
in eye pigmentation suggests that the P[w+18xSL] reporter is translationally 
repressed. In addition, reduction in eye pigmentation requires the presence of 
MCPSL in the mini-white 3ʼUTR; flies expressing P[GMA] and mini-white that 
lacks MCPSL, show no reduction in eye pigmentation (Fig. 4.1B). The 
combination of P[GMA] and P[w+18xSL] in flies provides a simple assay to 
screen for defects in translational repression. 
Genetic Screen 
We conducted an F1 clonal eye screen using the tethered AGO assay, 
searching for mutants with a darker eye phenotype (Stowers and Schwartz, 
1999). An F1 clonal screen has a number of advantages compared to other types 
of screens. An F1 screen allows detection of mutants in one generation. A clonal 
screen allows detection of mutants that are lethal as homozygotes.  FRT40A; 
P[w+18xSL] males were mutagenized and mated to FRT40A ey-FLP, GMR-
hid/CyO; P[GMA]/MKRS females. The progeny were examined to identify 
mutants with darker eyes (Fig. 4.2A). Roughly ten thousand F1 progeny were 
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screened. To retest and recover the mutants, flies with darker eyes were crossed 
to FRT40A eyFLP, GMR-hid; P[GMA] males or females (Fig. 4.2B). Seven 
mutants with altered eye color were recovered from retesting and subsequently 
named ta1-7. Five of these mutants carried recessive lethal mutations, where the 
lethal mutations may affect genes required for repression, or they may affect 
other genes. Two of the mutants were viable (ta2 and ta5), and homozygous flies 
had no obvious phenotypes.  
Complementation Tests  
The five mutants bearing recessive lethal mutations were tested for the 
ability to complement one another. Four lethal complementation groups were 
established. ta3 and ta4 failed to complement each other, suggesting the mutant 
chromosomes carry mutant alleles of the same gene (Table 4.1). To help define 
the genomic position of the shared lethal mutation, ta3 was tested for 
complementation with different Exelixis deficiencies, whose precise molecular 
deletions are known  (Parks et al., 2004). Three overlapping Exelixis deficiencies 
failed to complement ta3 (Table 4.2). However, these same deficiencies all 
complemented ta4. The simplest explanation for this result is that the ta3 
chromosome has more than one lethal mutation. The Exelixis deficiencies 
uncovered one these mutations, the one not shared with ta4.  
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miRNA-mediated regulation is important throughout development and 
mutants involved in regulation are expected to be pleiotropic. Different allelic 
combinations of a gene required for miRNA-mediated regulation could produce 
flies with an obvious phenotype. As a second approach to complementation 
tests, flies transheterozygous for two of the mutant chromosomes were examined 
for a phenotype that could then be used to test for complementation. Flies 
comprised of mutant chromosomes in trans to each other (all possible 
combinations) had no obvious phenotypes. As a third approach, we used the 
tethered AGO assay to look for complementation in transheterozygous flies. 
From the mutants tested so far, we established a complementation group that 
includes ta6 and ta7 (Table 4.3). We are currently testing the remaining mutants 
for complementation in trans to each other.  
Meiotic Mapping 
We mapped the ta mutations to genomic intervals in between visible 
markers through meiotic recombination. Recombinant chromosomes were 
generated from a mutant chromosome and a chromosome containing three 
recessive visible markers (al dp b FRT40A). Recombinant chromosomes 
containing the mutation were identified using the tethered AGO assay (Fig. 4.3, 
Table 4.4).  
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Using recombinant chromosomes, mutations were mapped to genomic 
regions between single nucleotide polymorphisms (SNPs). There are many SNPs 
already identified on the FLY SNP website (http://flysnp.imp.ac.at/), spaced an 
average distance of 50 kb apart (Chen et al., 2008). A number of these SNPs are 
also restriction fragment length polymorphisms (RFLPs). The presence of 
specific RFLPs between FRT40A/CyO flies and al dp b FRT40/CyO flies were 
verified and subsequently used for mapping (Table 4.5). Through RFLP mapping, 
we narrowed down the genomic regions that contain two genes discovered in the 
screen.  
ta1 
ta1 is the sole member of its complementation group (Table 4.1, Table 
4.3). The ta1 chromosome carries a lethal mutation, making it difficult to identify 
any obvious phenotypes present in adults (Table 4.1). Through meiotic 
recombination and RFLP mapping, the mutant gene was mapped between two 
SNP markers: 858 and 901. This placed ta1 in between genomic positions 
9,633,794 and 11,288,966, which consists of 1,455,172 nucleotides (Fig. 4.4). To 
more narrowly map ta1, we tested it for complementation with deficiencies using 
the tethered AGO assay.  All deficiencies tested complement ta1, but there are 
still a number of untested deficiencies that will be used to further map this mutant 
(Table 4.6, Fig. 4.4).  
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ta6 
ta6 and ta7 are different alleles of the same gene (Table 4.3). Flies 
transheterozygous for ta6 and ta7 had no obvious morphological defects. The 
genomic position of this gene was mapped between SNP718 and the dumpy (dp) 
locus, a 0.9 Mb region in between genomic positions 3,538,500 and 4,479,468 
(Fig. 4.6). This region consists of 88 annotated genes, none of which have 
previously been implicated in miRNA-mediated regulation. To more narrowly map 
ta6, we tested deficiencies for complementation with ta6 using the tethered AGO 
assay.  All deficiencies tested complement ta6 (Table 4.7).  A few other 
deficiencies remain to be tested, and will be used to further map this mutant (Fig.  
4.5). 
DISCUSSION 
Using a forward genetics approach, we have isolated mutants in 
potentially novel genes involved in miRNA-mediated regulation. Given the nature 
of our screen, these genes are likely to be involved in processes acting after 
Argonaute is targeted to an mRNA. Our assay relies on repression from tethering 
AGO1 to a reporter. Tethering Argonaute proteins to reporters mimics miRNA-
mediated regulation, bypassing targeting of a transcript using a miRNA, and may 
not depend on the miRNA processing machinery (Pillai et al., 2004; Rehwinkel et 
al., 2005). We recovered seven mutants through the screen, two being alleles of 
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the same gene. The fact that we recovered different alleles of only one gene 
suggests that there are still a number of unidentified genes on chromosome 2L 
involved in miRNA-mediated regulation, and that further screening with the 
tethered AGO assay will be productive. 
We have mapped the positions of two mutant genes to different genomic 
regions, both encompassing roughly a million nucleotides. Both these regions 
contain many genes, none of which have been implicated in miRNA-mediated 
regulation. The mutant genes can be further mapped using two tools:  
deficiencies and SNPs. We are currently in the process of identifying these 
genes, and are confident they encode novel components involved in miRNA-
mediated regulation. 
MATERIALS AND METHODS 
Production of the P[GMA] Transgene 
The P[GMA] transgene was constructed through multiple cloning steps 
and involved combining 3 components: the GMR promoter, the MCP coding 
region, and the AGO1 coding region and 3ʼUTR. Each component was first sub-
cloned into different vectors to facilitate cloning of all the components together. 
The GMR promoter was excised from pGMR (Hay et al., 1994) as a XhoI and 
EcoRI fragment and inserted into pSP72 (Promega). The XhoI site was 
subsequently changed to a KpnI site resulting in pJR7. The MCP gene was PCR 
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amplified from p8158 (primers: 5ʼ- 
CCGGAATTCCAAGGAGATATAACAATGGCTTCTAACTTTACTCAGTT-3ʼ and  
5ʼ- ATAAGAATGCGGCCGCCGTAGATGCCGGAGTTTGCTG-3ʼ), and cloned 
into pBSKS+ (Stratagene) as a EcoR1-(Kozak sequence-MCP start codon)-NotI 
(3ʼ MCP) resulting in pJR10. AGO1 nucleotides 1-929 were PCR amplified from 
the LD09501 cDNA (Drosophila Genomics Resource Center, Flybase Id 
FBcl0159390), and subsequently cloned into pBSKS+ as a NotI (5ʼAGO1)-HindIII 
fragment through PCR (primers: 5ʼ 
ATAAGAATGCGGCCGCATGTATCCAGTTGGACAACAGT-3ʼ and 5ʼ- 
CCCAAGCTTCACATGAAGTCAATGACTGGTT-3ʼ) and named pJR11. To 
construct an AGO1 fragment containing nucleotides 1-2098, a BspDI fragment 
from LD09501 was cloned into the BspDI site of pJR11, generating pJR12.   
Combining the different components into a transformation vector involved 
a number of cloning steps. An MCP-AGO1 (nucleotides 1-1474) fusion was 
created by cloning two fragments, a EcoRV(EcoRI-Kozak-MCP start codon)-
NotI(3ʼ MCP) MCP fragment from pJR10, and a NotI(5ʼ AGO1)-HindIII fragment 
containing AGO1 nucleotides 1-1474 from pJR12, into the pSP72 EcoRV-HindIII 
sites, generating pJR13. Then, a GMR-MCP-AGO1 (nucleotides 1-1474) fusion 
was generated by cloning two fragments, a KpnI-EcoRV GMR promoter fragment 
from pJR7, and a EcoRV(EcoRI-Kozak-MCP start codon) HindIII MCP:AGO 
fragment from pJR13, into the pBSKS+ KpnI-HindIII sites, generating pJR14. A 
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GMR:MCP:AGO1 transgene containing full length AGO1 was made by cloning 
two fragments, a KpnI-HindIII GMR:MCP:AGO1 fragment from pJR14, and a 
HindIII-KpnI AGOI 3ʼ fragment from LD09501,  into the pSP72 KpnI site, 
generating pJR8. The GMR-MCP-AGO1 fusion was inserted as a KpnI fragment 
into the transformation vector pJR1, which is pCarnegie20 (a gift from Janice 
Fischer) with the HpaI site converted to a KpnI site, generating pJR2 (P[GMA]).   
Production of the P[w+18xSL] transgene 
The P[w+18xSL] transgene was generated by first inserting a BamHI site 
into the mini-white 3ʼUTR. This was accomplished through PCR amplification of 
two fragments from the pCaSpeR (Drosophila Genomics Resource Center) mini-
white 3ʼUTR  (fragment 1 primers 5ʼ- 
CCGGAATTCTGACCAACATGACCTTTCAA-3ʼ and 5ʼ- 
CGCGGATCCGGGCAATAAACAGTAAACAC -3ʼ, fragment 2 primers 5ʼ- 
CGCGGATCCTTATTGCCCCCTCAAAAAGC-3ʼ and 5ʼ- 
CCCAAGCTTCTTTGGAGTACGAAATGCGT -3ʼ) and subsequently cloning them 
into pGEMI (Promega) as fragment 1 EcoRI-BamHI, and fragment 2 
BamHI/HindIII, generating pJR5. 18XMCPSL was inserted into pJR5 as a 
BamHI-BglII 18XMCPSL fragment from p8486, generating pJR4. The Nsi-BspDI 
mini-white 3ʼUTR 18XMCPSL fragment from pJR4 was cloned into pUAST 
(Brand and Perrimon, 1993), generating the pJR9 plasmid (P[w+18xSL). 
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Tethered AGO Screen 
FRT40A; P[w+18xSL]/TM2  flies were isogenized approximately two months 
before the genetic screen began. For mutagenesis, FRT40A; P[w+18xSL]/TM2  
males were left in a vial without food for 30 minutes, and subsequently 
transferred to a vial containing a kimwipe soaked in a 25 mM EMS, 1% sucrose 
solution. After 24 hours, the males were transferred to a clean vial for 30 minutes, 
and then crossed to females.  While crossing, the flies were transferred 
everyday, and the males were discarded on the fourth day following mutagenesis. 
The cross scheme in Figure 4.2A was used to generate flies of the desired 
genotype. Flies were examined for relief of repression by comparing 
FRT40A/CyO; P[GMA]/P[w+18xSL] to FRT40A ey-FLP GMR-hid; FRT40A; 
P[GMA]/P[w+18xSL] siblings. Mutants flies were re-tested using the cross 
scheme diagrammed in Figure 4.2B. 
RFLP mapping 
Genomic regions (approximately 1000 nucleotides) containing an SNP 
were PCR amplified from flies using primers and PCR conditions available on the 
FLY SNP website (http://flysnp.imp.ac.at/). PCR products were then digested 
using the appropriate NEB enzyme (www.neb.com/, Table 4.5), following NEB 
reaction conditions (http://www.neb.com/nebecomm/products/category1.asp?#2). 
Digestions of PCR products from FRT40/CyO and al dp b FRT40A/CyO flies 
 108 
were compared to verify the presence of an RFLP (Table 4.5). For mapping, 
digestions of PCR products from FRT40Arecombinant chromosomes/CyO flies 
were compared to digestions of PCR products from FRT40/CyO and al dp b 
FRT40A/CyO flies.   
Fly lines 
The following fly stocks were a gift from Janice Fischer: FRT40A flies, al 
dp b c px/CyO flies, al dp b Bl c px/ CyO flies, and FRT40A ey-FLP GMR-
hid/CyO flies (Stowers and Schwarz, 1999). Transgenes P[GMA] and 
P[w+18xSL] were injected by Genetic Services, Inc. The deficiency flies used in 
complementation tests are part of the Exelixis Deficiency kit and the BSC 
Deficiency lines, both are available from the Bloomington Stock Center. The al dp 
b FRT40A chromosome was generated through recombination between al dp b c 
px  and FRT40A chromosomes (recombination events from al dp b c px/FRT40A 
females). To test for the presence of the al dp b markers, recombinant al dp b 
FRT40A/CyO flies were crossed to al dp b Bl c px/CyO flies and the straight 
winged progeny were examined for the presence of the al dp b markers. To test 
for the presence of FRT40, al dp b FRT40A/CyO flies were crossed to FRT40A 
ey-FLP GMR-hid/CyO and the straight winged progeny were examined for the 
ability to make mitotic clones in the eye.  mini-white that lacks the 18xMCPSL 
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was  expressed in matalpha4-GAL-VP16 driver flies (Martin and St Johnston, 
2003). 
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Figures 
 
Figure 4.1. Repression of P[w+18xSL] in the eye. 
 
A.  Flies expressing P[w+18xSL] have orange eyes. When P[GMA] is expressed 
in combination with P[w+18xSL], it is able to bind and repress P[w+18xSL], 
leading to a reduction in eye color. 
B.  Translational repression of P[w+18xSL] requires the 18XMCPSL sequence.  
mini-white  lacking the 18X MCPSL is not able to bind MCP-AGO1, therefore, 
there is no reduction in eye color when P[GMA] is present. Eye color was 
examined in matalpha4-GAL-VP16 driver flies, which express mini-white. 
 111 
 
 
 
 
 
 
 
 
 112 
Figure 4.2. Cross scheme to identify mutants using a tethered AGO screen.  
 
A.  The F1 clonal eye screen. By making mitotic clones in the eye (Stowers and 
Schwarz, 1999), we were able to generate and screen for recessive mutations on 
chromosome 2L in one generation. All flies are in a w- background. 
B. Recovery and re-testing of mutants isolated from the screen. Potential mutants 
identified in A were immediately retested, allowing us to verify the presence of a 
mutation affecting repression in the tethered AGO assay, and to recover the 
mutant chromosomes. Parent genotypes listed without a male or female 
designation can be crossed as either males or females. All flies are in a w- 
background. 
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Figure 4.3. Generation of recombinant chromosomes used for mapping.   
 
Generation of recombinant, mutant chromosomes involved a number of crosses.  
First, different classes of recombinant chromosomes were generated and 
isolated, and then the recombinant chromosomes were screened for the 
presence of the mutant using the tethered AGO assay.   
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Figure 4.4. Genomic region containing ta1.  
 
ta1 has been mapped between SNP 858 and SNP 901. Shown here is a diagram 
of this region with the relative position of potential SNPs and deficiencies that 
could be used to further map this mutant. Deficiencies are listed as black bars 
that span the region of the deficiency. 
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Figure 4.5.  Genomic region containing ta6 and ta7. 
 
ta6 and ta7 are mapped between SNP 718 and the dp locus. Shown here is a 
diagram of this region with the relative position of potential SNPs and deficiencies 
that could be used to further map these mutants. Deficiencies are listed as black 
bars that span the region of the deficiency. 
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Table 4.1.  Complementation tests of the lethal mutations.   
 
Complementation of lethal mutations associated with different mutant 
chromosomes were tested for using all possible mutant combinations. The 
symbols represent mutant combinations that were either lethal (-) or viable (+). 
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Table 4.2. Complementation tests of the ta3 mutant chromosome with 
Exelixis deficiencies.   
 
Listed are the deficiencies used to test for complementation, whether they 
complemented the lethal mutation on the ta3 mutant chromosome, and the 
deficiency breakpoints. 
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Table 4.3.  Complementation tests using the tethered AGO assay.   
 
Complementation between different mutants was tested for using the tethered 
AGO assay. The symbols represent mutant combinations that either 
complemented each other (+), or did not complement each other (-). Blank boxes 
indicate mutant combinations not yet tested. 
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Table 4.4.  List of recombinant chromosomes generated for mapping. 
 
Recombinant chromosomes were generated as in Figure 4.3. Recombinant line 
names are listed as the mutant used to generate the recombinant (ta 
designation) followed by the recombinant line number. The table contains 
information regarding the presence of the mutant, the class of recombinant 
generated, and RFLPs present from the FRT40A chromosome or the al dp b 
FRT40 chromosome (all the RFLPs tested for each line are listed). The 
recombinant chromosome class is listed as a combination of recessive marker 
alleles (al dp b) and wild type alleles (+), in the gene order al dp b. 
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Table 4.5.  List of verified RFLPs.  
 
RFLPs were tested in lab between the FRT40A and al dp b FRT40A 
chromosomes. Listed are the restriction enzymes that produced a different 
banding pattern when comparing digests of PCR products (see Materials and 
methods) from FRT40A/CyO and al dp b FRT40/CyO flies. 
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Table 4.6.  Complementation tests of ta1 with deficiencies.   
Complementation was tested for between ta1 and the listed deficiencies using 
the tethered AGO assay. Listed are the deficiencies used, whether they 
complement ta1, and the deficiency breakpoints.   
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Table 4.7. Complementation tests of ta6 with deficiencies.    
 
Complementation was tested for between ta6 and the listed deficiencies using 
the tethered AGO assay. Listed are the deficiencies used, whether they 
complement ta6, and the deficiency breakpoints.   
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Summary 
 
A major focus of this thesis is miRNA-mediated regulation.  miRNAs are 
small RNAs involved in post-transcriptional regulation of many genes. miRNA-
mediated regulation is essential during the development of a number of 
organisms, and can occur through multiple mechanisms. Although there is a lot 
of interest in how miRNAs mediate repression, the mechanisms of how this 
occurs are not well understood. Determining where repression occurs in cells, 
and the proteins involved in repression, can provide clues about how miRNAs 
regulate genes post-transcriptionally. To elucidate how miRNAs mediate 
repression in Drosophila, we examined where repression occurs in the ovary.  To 
accomplish this, we designed an ovarian assay to monitor miRNA-mediate 
repression, and found that this form of regulation is active in the ovary, and 
occurs in the absence of mRNA degradation.  Next, we examined where 
repression occurs. We found that transcripts regulated by miRNAs localize to 
cytoplasmic puncta, and localization was indistinguishable from that of non-
repressed transcripts. This suggests that miRNA-mediated regulation in the ovary 
may occur on transcripts that are associated with actively translating ribosomes, 
and therefore may affect a step of translation that follows initiation.  In addition, 
localization of repressed transcripts in our assay differs from other published 
reports in Drosophila, and may suggest a different mechanism of repression than 
what has been observed previously. The ovarian assay we developed can be 
further used to investigate the mechanism of repression mediated by miRNAs in 
the ovary.  In addition, we have identified a number of mutants involved in 
miRNA-mediated repression through a genetic screen.  The identities of these 
mutant genes are unknown, but they may represent novel components involved 
in miRNA-mediated repression.   Once discovered, I believe their identities will 
vastly increase our understanding of repressive mechanisms utilized by miRNAs. 
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In this thesis we also examine the oskar (osk) mRNAs role in egg chamber 
progression through oogenesis. The osk mRNA has two essential roles in 
Drosophila development: it codes for the Osk protein, which is required for 
posterior body patterning, and it has an unidentified, essential role in egg 
chamber progression through oogenesis, which is mediated by its 3ʼ UTR. The 
osk mRNA is a highly regulated, and expression of the mRNA is controlled by 
osk localization within the oocyte, and translational repression of osk until it is 
localized. Many factors involved in translational regulation of osk have been 
identified, but almost nothing is known about the 3ʼ UTRʼs function in egg 
chamber progression through oogenesis. Here we demonstrate that sequences 
within the osk 3ʼ UTR called BREs (Bruno Respone Elements), are required for 
progression through oogenesis. The BREs were originally identified as 
sequences required for translational repression of osk, and they mediate 
repression through binding to the translational repressor Bruno (Bru). Given this, 
we tested whether the Bru-BRE interaction was also required for egg chamber 
progression through oogenesis.  We found that this interaction is necessary, and 
provide evidence that the BREs sequester Bru, possibly preventing Bru from 
misregulating other ovarian RNAs.  Our work suggests that the osk BRE-Bru 
interaction provides a novel regulatory loop, where Bru binding to BREs prevents 
ectopic expression of Osk protein, and the osk BREs binding to Bru titrates the 
concentration of free Bru, preventing misregulation of ovarian mRNAs. This is the 
first documented example of this type of regulatory loop, where an mRNA is 
repressed by a protein, and the mRNA in turn modulates the repressive activity of 
that protein.  Although this is the first example of this type of regulatory loop, it is 
unlikely to be the last.  In the future, we may find other examples of this novel 
regulatory loop throughout the development of a number of organisms. 
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